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Abstract 
Regeneration of the adult rat liver in response to severe damage can be 
accomplished through the activation and differentiation of multipotential  nonparenchymal 
progenitor cells (oval cells). Despite considerable research efforts during the past years, 
only little is known about the implicated molecules, and thereby the mechanisms, which 
control the actions of  oval  cells.  In  this  study,  Suppression  Subtractive  Hybridization  (SSH) 
and Signal Peptide Selection (SPS), was applied on liver cDNA libraries generated from 
rats  exposed to feeding  with  2-acetylaminofluorene  (2-AAF) and a 70% partial 
hepatectomy  (PHx),  in  order to map genes that are  highly  expressed  when  oval  cells are 
activated  and  recruited  for  liver  regeneration. 
From  the SSH library, 29 known and five  novel  unique  cDNA  sequences  were 
identified.  Additionally  four  sequences matched expressed sequence tags (ESTs). A 
subset  of  the  identified  genes;  interferon-y  receptor a subunit  (IFN-yRa), gpglphox, 
interleukin-l P (IL-lp), lymphocyte function associated molecule-la (LFA-l), eukaryotic 
initiation factor-2-associated 67-kd protein and a-fetoprotein (AFP), constitutes a part of 
the  gene  network  connected to interferon-y  (IFN-y). The study  was  therefore  extended to 
include;  IFN-y,  the  IFN-y  receptor P subunit  (IFN-.PP),  three  secondary  response  genes of 
IFN-y, i.e., IL-lP-converting enzyme  (ICE), intercellular adhesion molecule-l  (ICAM-l), and 
urokinase-type  plasminogen  activator  receptor  (uPAR),  as  well  as interleukin-l8 (lL-l8), a 
cytokine  which  induces  expression of IFN-y by  T lymphocytes.  Expression  analysis of all 
the genes was  performed  by  Northern blotting and immunohistochemistry.  Increased 
expression of the entire examined gene network was detected in response to oval cell 
activation  by  2-AAF  and  the  expression  increased  further  when  extensive  proliferation of 
oval  cells  was  induced  by a subsequent  PHx.  During  simple  regeneration  after  PHx,  only 
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modulation of IL-lp and  ICE  was  observed.  The  expression  of  the  IFN-y  receptor  complex, 
uPAR, ICAM-1, IL-l8 and ICE  could be localized  to  the  ductular  structures of oval cells. 
These  results  indicate  that  IFN-y  mediated  events may be particularly  important  when  cells 
in the bile ductules must  respond to liver  damage  by  production of oval  cells. 
SPS combined  with  Northern  blot  analysis  was  introduced in the  present  study 
in order to focus on  genes  encoding  secreted  and  membrane-bound  proteins  specifically 
associated  with  regeneration from oval  cells.  Twenty two unique  cDNAs  encoding  eighteen 
known membrane-bound or secreted proteins, and four novel proteins were identified. 
Northern blot analysis in various experimental models of liver damage and regeneration 
showed that one transcript encoding leukocyte-common antigen-l (CD45) and the four 
novel transcripts  were  specifically  associated  with  progenitor  cell  activity of the oval cell 
phenotype. Additional expression analysis of genes linked to the function of CD45 (i.e. 
Thy-l, the  chemokine  receptor  CXCR4,  and  SDF-1,  the  ligand for CXCR4)  further 
indicated a  role for CD45  in oval cell-based  liver  regeneration. 
One of the novel  cDNAs  from  the SPS library, aocpl (associated  with oval cell 
proliferation l) ,  appeared  especially  interesting  as  its  expression  was  highly  restricted to 
the 2-AAF and 2-AAFIPHx protocols. Northern blot analysis of multiple adult rat tissues 
revealed  that aocpl was  exclusively  expressed in the  testis,  indicating its putative  role in 
both oval cell  based  liver  regeneration  and  spermatogenesis. 
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Dansk resume 
Beskadiges  leveren i den  voksne  rotte  voldsomt, kan  det  regenerative  respons 
foregi via  aktivering  og  differentiering  af  multipotente  ikke-parenchymale  stamcelle- 
lignende celler (kaldt ovale celler). Trods omfattende forskning indenfor de seneste i r  
vides  kun  lidt  om  de  implicerede  molekyler, og dermed  hvilke  mekanismer,  der  kontrollerer 
aktiviteterne  af  ovale  celler. I det  foreliggende  studie  blev  Suppressions  Subtraktiv 
Hybridisering (SSH) og  Signal  Peptid  Selektion  (SPS)  anvendt p i  cDNA  biblioteker, 
genereret  fra  rotter  eksponeret  for  fodring med 2-acetylaminofluorene  (2-AAF)  og  en  70 % 
partiel  hepatektomi  (PHx), med det formil at  kortlzegge  gener  der  er hojt udtrykt n i r  ovale 
celler  aktiveres og rekrutteres  ved  leverregeneration. 
Fra SSH biblioteket  blev  der  identificeret  29  kendte og 5 hidtil  ukendte  unikke 
cDNA sekvenser. Yderligere 4 sekvenser var identiske med "udtrykte sekvensender" 
(expressed sequence tags (ESTs)). Nogle  af de identificerede gener:  interferon-y  receptor 
a subunit (IFN-yRa), gpglphox, interleukin-lP (IL-l P), lymphocyte function associated 
molecule-l a (LFA-l), eukaryotic  initiation  factor-2-associated 67-kd protein and a- 
fetoprotein  (AFP), udgm en  del af  det  gen-netvaerk  der  er  forbundet til interferon-y  (IFN-y). 
Derfor blev studiet udvidet til at inkludere: IFN-y, IFN-y receptor P subunit (IFN-yRP), 3 
sekundzere  respons  gener til IFN-y, mere przecist IL-lP-converting enzyme  (ICE), 
intercellular adhesion molecule-l (ICAM-l) samt urokinase-type plasminogen activator 
receptor @PAR), og ligeledes interleukin-l8  (lL-l€?), et cytokin der  inducerer 
ekspressionen af IFN-y fra T lymfocytter. Ekspressionsanalyse af alle disse gener blev 
foretaget  ved  Northern  blotning  og  immunohistokemi.  For  hele  det  undersogte  gen- 
netvaerk blev  der pivist @get  ekspression som respons p i  oval  celle  aktivering  via 2-AAF 
og ekspressionen ogedes yderligere n i r  omfattende  celledeling  af  ovale  celler  blev 
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induceret  ved  en efterf~lgende PHx. Under  simpel  regeneration efter en PHx var  det  kun 
ekspressionen af IL-lp og  ICE  der  blev  aendret.  Ekspressionen af IFN-y receptor 
komplekset, uPAR, CAM-l,  IL-l8 og ICE  kunne  lokaliseres til de r~rstrukturer der best& 
af ovale  celler.  Disse  resultater  indikerer  at pivirkninger der  er  en f ~ l g e  af IFN-y's 
tilstedevaerelse  kan  vaere  af  stor  vigtighed  nAr  celler i  galdegangene  responderer p5 lever 
beskadigelse  via  produktion af ovale  celler. 
SPS kombineret  med  Northern  blot  analyse blev introduceret i det 
foreliggende  studie  med formilet at  fokusere p& de  gener  der  koder for secernerede og 
membranbundne proteiner,  som  specifikt  er  associeret med regeneration  fra  ovale  celler. 
22 unikke cDNAer, kodende for 18 kendte membranbundne eller secernerede  proteiner 
og 4 nye proteiner, blev identificeret. Northern blot analyse i forskellige eksperimentelle 
modeller  for  leverskade  og  -regeneration  viste  at  et af de  kendte  transkripts,  kodende  for 
leukocyte-common antigen-l (CD45), samt de 4 nye transkripts, specifikt var associeret 
med aktivitet  af  celler  med  oval  celle fEnotype. Opf~lgende ekspressionsanalyse af gener 
der er forbundet med funktionen af CD45 (her Thy-l, kemokin receptoren CXCR4, og 
SDF-1, liganden for CXCR4) indikerede yderligere en rolle for CD45 i leverregeneration 
baseret p i  oval  celler. 
Et af de nye cDNA'er fra SPS biblioteket, aocpl (associated with oval cell 
proliferation l ) ,  fremstod  som  specielt  interessant, da ekspressionen  var  helt begraenset til 
2-AAF og 2-AAF/PHx protokollerne. Northern blot analyse af adskillige vaev fra voksne 
rotter viste, at aocpl udelukkende blev udtrykt i testis, hvilket kunne indikere at aocpl 
spiller  en  rolle bide i  leverregeneration  baseret p i  ovale  celler og ved  spermatogenese. 
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Abbreviations 
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AA 
AFP 
aocp 
APAP 
BDL 
BMTx 
cDNA 
cd k 
CH0 
CK 
DPPIV 
ECM 
EGF 
EGFR 
EST 
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GalN 
GGT 
HGF 
HNF 
CAM-1 
ICE 
IL(-6,-18) 
IFN-y 
LFA-1 
LIF 
2-acetylaminofluorene 
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a fetoprotein 
Associated  with  Oval  Cell  Proliferation 
Acetaminophen 
Bile  duct  ligation 
Bone  marrow  transplantation 
Complementary DNA 
Cyclin  dependent  kinase 
Chinese  hamster  ovary 
Cytokeratin 
Dipeptidyl  peptidase IV 
Extracellular  matrix 
Epidermal  growth  factor 
Epidermal  growth  factor  receptor 
Expressed  sequence  tag 
Fetal  liver  hematopoietic stem cell 
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Hepatocyte  growth  factor 
Hepatocyte  nuclear  factor 
Intercellular  adhesion molecule-l 
IL-l P-converting  enzyme 
Interleukin-6, -18 
Interferon-y 
Lymphocyte  function-associated 
molecule-la 
Leukemia  inhibitory  factor 
LlFR 
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NF-KB 
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PCR 
SCF 
SDF-1 
SSH 
SPS 
STAT1, -3 
TGF-cx 
TNF-ru 
TNFR-l 
uPA 
uPAR 
UTP 
W  LTx 
Leukemia inhibitory  factor  receptor 
Lipopolysaccharide 
Nuclear factor KB 
Nonparenchymal  cells 
Plasminogen  activator inhibitor-l 
plaque forming units 
Partial  hepatectomy (70%) 
Polymerase  chain  reaction 
Stem cell factor 
Stromal cell derived factor-l 
Suppression  Subtractive 
Hybridization 
Signal  Peptide  Selection 
transcription protein 1 or 3 
Signal  transducer  and  activator of
Transforming growth factor-a 
Tumor necrosis factor-a 
Tumor necrosis factor receptor-l 
Urokinase-type  plasminogen 
activator 
Urokinase-type  plasminogen 
activator  receptor 
Uridine  nucleotides 
Whole liver  transplantation 
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1. Introduction 
1 . l .  Organization of the hepatic parenchyma 
In  adults, the liver  performs  myriad  functions. It is  the  main  producer of blood 
plasma  proteins and a  major site for  metabolism.  These  activities  include  synthesis  and 
secretion of acute phase proteins,  binding  proteins  for  steroid  hormones,  lipoproteins  and 
clotting  factors  like  fibrinogen,  digestive  functions  via  bile  production  and  secretion,  organic 
metabolism including conversion and production of glucose, cholesterol metabolism and 
metabolic  alterations of foreign organic  molecules  by the microsomal  enzyme  system,  e.g. 
hydroxylation  reactions. 
The main cell type of the adult  liver is  the  hepatocyte  which  carries  out  most  of 
its functions, but the organ further include: Cholangiocytes lining the Canals of Hering; 
fenestrated  endothelial cells which  are  unique  among  endothelial  cells  due to their  large 
cytoplasmic gabs that allow maximal contact between blood and hepatocytes; Kupffer 
cells,  which  correspond to macrophages localized in  hepatic  sinusoids; and Ito  cells 
located under the sinusoids, the fat storing cells which are unique to the liver and 
synthesize  connective tissue proteins and secrete  several  growth  factors  (Gressner, 
1995). 
In the adult,  rat  hepatocytes  are  stacked  into  plates of cells which  are one-cell 
wide and up to 20 cells long, and which bifurcate and merge freely (McCuskey, 1993). 
Epithelial cells of bile ducts, ductules and hepatocytes form a continuous cellular array; 
ductules are joined at the portal ends of plates to bile canaliculi which occupy the 
intercellular  space between adjacent  hepatocytes  and  the  canalicular  network  drains  the 
bile  produced  by the hepatocytes to the portal tract  interface  (Figure  1). 
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Figure 1. Part of a microsegment 
of a liver parenchyma. CV, central 
vein; K, Kupffer cell; FSC,  fat 
storing cell (Ito cell): BC,  bile 
canaliculus; En, endothelial cell; S, 
sinusoid  with fenestrations; DS, 
space of Disse  (separates  the 
hepatocytes  from  the  sinusoidal 
wall);  Hab,  hepatic  artery  branch; 
PVb, portal vein  branch;  CDJ, 
caniculo-ductular junction (Canals 
of Hering); BDI, bile ductule: LmP, 
limiting plate; LP, liver plate. From 
Muto  and  Yamamoto (1978). 
The  continuous  mass of hepatocytic  plates  is  organized in lobular  structures  called  hepatic 
lobules,  which in a  2-dimensional  view is organized like a  wheel,  which  is  interpenetrated 
by two distinct  vascular  beds;  a central vein and six sets of portal  triads. The portal  triads 
(also  known  as portal tracts  or portal spaces) are composed of microscopic  branches of 
three vessels: A portal vein, a hepatic artery and a bile ductule. The portal vein brings 
blood to the liver from the intestine,  the  stomach,  the  pancreas,  the  gallbladder  and the 
spleen  and  this blood is  mixed  with the highly  oxygenated  arterial  blood  in the sinusoids 
and the mixed blood flows towards the central vein. The bile ductule carries the bile 
produced  by  hepatocytes  away to  the larger  bile  ducts. 
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Despite  extensive  studies  for more than  a  century, the liver anatomy is still not 
fully  understood. The overall  organization of the organ  is  well  described,  but at the  level of 
microanatomical  interfaces,  the  relationships  between  the  vascular  tree, the biliary  system 
and the hepatic  parenchyma  still  appears  inadequately  explained.  Thus, the definition  of 
an  independent  functional  unit  is  presently  debated.  The  status  on  this  subject  is  reviewed 
by Saxena et a/. (1  999). 
1.2. Liver development 
During  gastrulation  the  endoderm  forms  the  primordium  of the digestive  tract. 
In addition to the  pharynx,  the  esophagus,  the  stomach  and  the  intestines,  it also gives  rise 
to many associated  glands,  including  the  salivary  glands,  the  pancreas and the liver. The 
endoderm forms the epithelial  components of these structures while the supporting 
muscular and fibrous elements arise from the mesoderm. In the developing liver the 
ventral foregut endoderm gives rise to primitive hepatoblasts, whereas sinusoidal-lining 
cells and connective  tissue  components  originate  in  the  mesenchymal  tissue  invaded  by 
the liver  cords  (Shiojiri et a/, 1991). By  use of in situ hybridization and 
immunohistochemical  techniques,  Shiojiri et a/ (1991)  conducted comprehensive studies to 
examine cell lineages  during  rat  liver  development.  Differentiation  was  monitored  by  use 
of the markers a-fetoprotein (AFP) and albumin (hepatocyte specific), gamma glutamyl 
transferase (GGT) (bile duct specific) and cytokeratins (CKs) (adult  hepatocytes  contain 
only CK8 and  CK18,  while  duct  cells in addition  contain CK7 and CK19 (Moll et a/, 1982; 
Van  Eyken et a/, 1987)). It  was  shown  that the endodermal  epithelial cells constituting the 
adult liver (hepatocytes and bile ducts), all originate from AFP producing, bipotential 
hepatoblasts. The hepatoblasts which surround the portal mesenchyme form a double- 
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layered  cylinder  which  remodels  and  migrate  into  the  mesenchyme to form  the  intrahepatic 
bile ducts (Van Eyken et a/, 1988; Shiojiri et af, 1991). The hepatoblasts express AFP, 
later also albumin and GGT, as they migrate into the portal stroma. Initially, intermediate 
expression  is  restricted to CK8  and  -18,  but  during  later  stages of ductular  morphogenesis, 
the ductal cells begin to express CK7 and -19 as well (Moll et a/, 1982). In contrast, 
hepatoblasts  which  are  not  in  contact  with  the  portal  mesenchyme  differentiate  into 
hepatocytes  which  form  the  liver  cell  plates  and  CK  expression is restricted to CK8  and - 
18. 
1.3. The  phenomenon of liver regeneration 
The  liver of an adult individual is normally  a  mitotically  quiescent  organ. The 
mass of the liver  is,  however,  precisely  regulated  and  in case of cellular loss, it 
demonstrates  a  remarkable  regenerative  capacity. This characteristic has been  known  by 
mankind all the  way back to the  ancient  Greeks  as  it  emerges  from the myth of 
Prometheus. Prometheus stole the secret of fire from the gods of the Olympus and 
brought it to the human beings. As a punishment the gods condemned him to have a 
portion  of his  liver  eaten  by an eagle  daily. The liver  regenerated  overnight  and the torture 
could  continue  for  ever. A consistent model for  studying the phenomenon of  liver 
regeneration  was  introduced  by  Higgins and Anderson  (1931).  In this model,  two-thirds of 
a rat liver is removed by surgery (partial hepatectomy, PHx), which, in the terminology 
used by Higgins and Anderson, corresponds to the median and left lateral lobe. The 
residual  lobes  are  left  behind  intact and enlarge to make up  for  the  reduced  liver  mass,  a 
process which is completed within 1-2 weeks. The process of regeneration in the PHx 
model  differ  from  that  seen  in  other  regenerating  tissues, e.g. bone marrow or  skin,  as it 
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apparently  does  not  involve  progenitor or stem  cells.  Resection  triggers the hepatocytes in 
the  remnant  lobes to exit  the Go phase and they  enter DNA synthesis  about 12 hours after 
PHx, while the other cells of the liver enter into DNA synthesis about 24 hours later 
(Michalopoulos and DeFrances,  1997). 
However, in real life liver mass reduction is caused by toxic injuries from 
agents like viruses and chemicals rather than by surgery, and some of these injuring 
agents do not  only cause mass  reduction,  but  also  impair or  block  the  proliferative  capacity 
of hepatocytes. As described more thoroughly below, the organ may then turn to an 
alternative  strategy of regeneration  by  proliferation,  migration  and  ifferentiation  of 
progenitor cells forming atypical  structures  initially  continuous  with  the  biliary  tree  (Alison, 
1998).  In  rodents,  these  progenitor  cells  are  called  oval cells due to morphological 
appearance of the nucleus  (Faber,  1955).  They  share the characteristics of fetal 
hepatoblasts and possess a multi-potent progenitor cell potential which, in vivo, include 
differentiation  along  hepatocyte  and bile duct  lineages,  but  also  intestinal  type  epithelium 
(Alison et a/, 1998;  Lemire et a/, 1991 ; Evarts et a/,  1996;  Tatematsu et al, 1985). 
Elucidation of the mechanisms which control the actions of oval cells has 
become an important issue as similar atypical ductular reactions have been identified in 
many forms  of  human  chronic  liver  diseases  (Lowes et a/, 1999)  and  due to the  ability of 
oval cells to replace  hepatocytes  (Evarts  et a/ 1996).  Identification of the  key  molecules 
which  control oval cell actions  could  influence  on  future  treatment  strategies  in  the  clinic, 
as  liver  progenitor  cells  as  therapeutic  targets  would  make  it  possible to e.g.: initiate the 
process of oval cell differentiation which fail in chronic liver diseases; activate oval cells 
and their  developmental  potential  as  an  alternative  to  transplantation or  stop the 
14 
proliferation of ductular cells in situations of uncontrolled growth, e.g. in response to 
acetaminophen  (APAP)  induced  injury  (Lowes et a/, 1999). 
1.4. Regeneration  from  oval  progenitor cells 
The subject of regeneration from liver stem cells has been controversial for 
decades,  partly  because  no  one so far  has  been able to demonstrate  neither the 
localization  nor  the  exact  nature of such  cells.  It  is,  however,  well  established,  that  injuries 
which  impair  the  proliferative  capacity  of  hepatocytes  may  result in proliferation of 
epithelial (oval)  cells,  in  which fetal liver-specific  gene  expression  is  recapitulated. The oval 
cells themselves  are  considered to represent the progeny of  liver  stem  cells,  as  they  are 
associated with impaired regeneration, and because they express markers identified as 
characteristic of  stem  cells,  e.g. stem  cell  factor  (SCF), its receptor c-kit and cytokeratin 14 
(Fuji0 et a/, 1994;  Bisgaard et a/, 1994).  Markers for oval  cells  are  shown in Table  1. 
Rats have been used most extensively to generate experimental protocols 
which  initiate  oval  cell  proliferation  (reviewed  by  Alison et a/, 1998). These include feeding 
with a choline-devoid ethionine diet (Tee et a/, 1994); 2-acetylaminofluorene (2-AAF) 
administration (Bisgaard et a/, 1996); D-galactosamine (GalN) exposure (Lemire et a/, 
1991); feeding with a 3-methyl diaminobenzidine containing diet (Carthew et a/, 1989); 
long term exposure to ethanol (Smith et a/, 1996); toxic accumulation of copper due to 
defect in Wilson  disease  gene  (Long-Evans  Cinnamon  rat)  (Betto et a/, 1996);  and  2-AAF 
in a choline  devoid  diet  or  combined  with  PHx,  carbon  tetrachloride (C&)  or allyl  alcohol 
(AA),  (Sell,  1983;  Evarts et a/, 1987;  Petersen et a/, 1998 b).  Central to all these  models  is 
the extensive destruction and/or compromised function of hepatocytes, coupled with the 
apparent  inability of  the residual  hepatocytes to proliferate.  However,  only the models of  D- 
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Marker(s) Notes I References 
i l 
AFP, albumin Goldin et a/. (1995), Alison et AFP  synthesis ceases upon hepatocyiic differentiation 
a/.  (1997) 
l I 
CKs  7,8,  18 and 19 
CK14 
Alison et a/.  (1996)  Highly expressed biliary cytokeratins. Hepatocytes express CK8 and -18. 
Hixon etal. (1997) cytoskeletal proteins in oval cells. OV6 labels most oval cells, OC2 and OC3 OV6,  OC2,  OC3 
Alison et a/.  (1997)  Mesenchymal intermediate iilament expressed by migrating oval celis Vimentin 
Fujio et a/.  (1994) Only  expressed  by  a  minority of oval cells 
label sub-populations 
BD1 'fang et a/.  (1993)  This is a negative marker as it recognizes  mature biliary epithelia but does  not 
immunostain oval cells 
GGT Yang etal. (1993) Both bile duct epithelial and  oval cells stains for this marker 
Thy-l 
SCFlc-k/t 
Petersen et al. (1998 a) Cell  membrane-bound  giycoprotein also expressed by  haemopoietic  cells 
stem  cells in hematopoiesis, gametogenesis  and melanogenesis. 
SCF and its receptor is implicated in suwival, proliferation and differentiation of Fujio eta/. (1996) 
CD34 Omori eta/. (1997) A glycophosphoprotein which selectively identifies essentially all lineages oi 
hematopoietic stemlprogenitor cells 
Table 1. Markers for  val  cells.  Antigens  expressed by oval cells which  an  be  detected 
immunocytochemically. The antigens are not expressed by oval cells only, but many are very highly 
expressed and can be used to  highlight  the presence of oval cells in histological  sections  and  can be utilized 
in cell sorting.  Modified from Alison (1998). 
Galactosamine (GalN) administration or administration of the carcinogen  2-AAF  in 
combination with  PHx,  have  been  documented to result  in  extensive oval cell proliferation, 
migration and finally differentiation into hepatocytes (Lemire et a/, 1991; Dabeva and 
Shafritz, 1993; Evarts et a/, 1987; Evarts et a/, 1996). 
Irrespective to the localization of facultative stem cells, the oval cells in the 
GalN and 2-AAF/PHx models originate in portal zones in the regions of terminal bile 
ductules and then emerge from the portal regions,  invade the entire  lobular  parenchyma 
and differentiate (Grisham  and  Thorgeirsson, 1996). By  light  microscopy  studies  Sarraf et 
a/ (1994) showed  that oval cells in the 2-AAF/PHx protocol initially  expand  from,  and  are 
continuos with, the biliary tree.  By detection of  AFP  and CK19 expression  it has 
subsequently  been  shown, that it is the smaller  interlobular  ducts that are  heavily 
implicated,  rather than the larger  ducts (Alison et a/,1998). The area from  which the oval 
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cells appear to expand, and possible differentiation lineages, identified by in vivo and in 
vitro studies,  is  shown in Figure  2. 
stem cells 
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Figure 2. Schematic representation 
of the  localization from which  the  oval 
cells expands. The scheme shows 
the  developmental  options  that  he 
oval  cells possess, including 
differentiation into hepatocytes  and 
biliary  epithelium.  BD:  Bile  ductule: 
CH: Canal of Hering. Redrawn and 
modified from Grisham  and 
Thorgeirsson (1996). 
Recent  studies  in  rats,  mice and humans  have  shown that extrahepatic 
derived  cells of bone marrow origin also can contribute as a  source of hepatocytes  and 
bile duct cells  in  liver  regeneration  and  renewal  (Petersen et a/, 1999; Theise et a/, 2000  a; 
Theise et a/, 2000  b). In the  study  by  Petersen et a/ (1999),  three  approaches  were  used  in 
conjunction with the 2-AAF/CC14 protocol: i) bone marrow transplantation (BMTx) from 
male  rats  into  lethally  irradiated  females  and  detection of  donor  cells in the recipients  by 
means of DNA probes to the Y chromosome; ii) BMTx from dipeptidyl peptidase IV- 
positive (DPPIV') male  rats  into  DPPIV-  females  and  detection  of  DPPIV  -expressing  cells 
in the recipient animals and; iii) whole liver transplantation (WLTx) with L21-6 antigen 
expressing  recipients of  livers  from  rats  that  did  not  express  the L21-6 antigen. In 
summary, all approaches  confirmed  that  a subpopulation  of  the oval cells and/or 
hepatocytes  and  ductular  structures  derived  from  the  donor  bone  marrow cell population 
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and  in  case of  approach  iii),  a  widespread  staining for L21-6  was  detected  as  a  result of 
the  influx of oval  cells  that  originated  from an extrahepatic  source of the recipient  rats.  The 
contribution of donor derived hepatocytes in approach i) and ii) was quantified at a time 
when the oval cells had started to differentiate into hepatocytes and was estimated to 
about 0.14% and 0.16% of the total hepatocytes,  respectively. The proportion of Thy-l+ 
oval  cells  expressing  the  Y  marker in approach  i)  was  calculated to about 0.1%. 
An  approach  based on lethal  irradiation of female  mice  which  received  whole 
bone  marrow  transplants  from  male  donors  was  used in the study  by Theise et a/ (2000 a) 
but  a  protocol  directed  towards  liver  specific  injury  was not included  in  these  experiments. 
Y-chromosome positive hepatocytes constituted about 1 to 2 Yo of total hepatocytes in 
animals  sacrificed 2 month  or  longer  posttransplantation,  indicating that stem  cells of bone 
marrow origin may take part in normal tissue renewal in the liver. Liver specimens from 
human  recipients of therapeutic bone marrow  liver  transplants  have also been  analyzed for 
marrow-derived hepatocytes and biliary epithelium cells (cholangiocytes) (Theise et a/, 
2000  b).  The  pathological  cases  included  chronic  myelogenous  leukemia,  primary 
sclerosing cholangitis, alpha-l antitrypsin deficiency and hepatitis C. Engraftment of Y- 
chromosome  positive  hepatocytes and cholangiocytes  was  detected in all  specimens,  with 
adjusted values ranging from 4 to 43 '70 and 4 to 38 %, respectively, showing that in 
humans too, hepatocytes and biliary epithelium cells can be derived from extrahepatic 
stem  cells,  probably of  bone  marrow  origin. 
1 S. Activation of oval  cells 
As  described  above,  several  experimental  protocols,  which  provoke  a
regenerative  response  involving oval cells,  exists. The mechanisms  which  activate  the  oval 
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cells and the reason  why  only the 2-AAF/PHx (or 2-AAF -t an  alternative  injury) and  GalN 
protocols  results  in  a  complete  regenerative  process, is, however,  poorly  understood. The 
nature of injuries in the noncarcinogenic GalN protocol and the carcinogenic 2-AANPHx 
protocol  are  quite  different. When introduced into rats at concentrations higher than 200 
mglkg, GalN causes a series of metabolic reactions to occur in the hepatocytes, most 
notably a complete consumption of all uridine nucleotides (UTPs). The UTP trapping 
results in blocked RNA synthesis, followed by inhibition of protein synthesis, changes in 
plasma membranes and  finally  hepatocyte  death  (Decker  and  Keppler, 1972; Decker and 
Keppler, 1974; Bachmann et a/, 1977). The  nonparenchymal  cells  are  not  targets  for UTP 
trapping and oval cells start to replicate  at  day 1 (Lemire et af, 1991). Hepatocytes  recover 
in the GalN protocol at day 3 and thereby contribute to the restoration of normal liver 
structure  which  is  completed  within  only 7 -10 days  (Lemire et a/, 1991). 
The tissue  destruction  and  oval  cell  activation  is  obtained in  the  GalN  protocol 
by use of one or two (6 hours apart) intraperitonal doses (Dabeva and Shafritz, 1993; 
Lemire et a/, 1991), while  2-AAF in all variations of the 2-AAF/PHx  protocol is 
administrated  daily  for  at  least 9 days  and  PHx  is  typically  performed  at  the  midway  point 
(reviewed  by  Alison et a/, 1998). Hepatocytes  do  not  contribute to the  tissue  restoration  in 
these  protocols  and  whether  oval  cells  differentiate  into  hepatocytes or undergo  intestinal 
metaplasia  appears to depend on the  amount of 2-AAF  administrated.  DNA  synthesis  in 
oval cells and Ito  cells  is  seen  already at  four  hours  after  PHx  (Thorgeirsson et a/, 1993), 
but  proliferation of oval  cells is not  extensive  for  the  first  several  days  after  PHx  and the 
period  prior to differentiation  into  hepatocytes  is  prolonged  when  compaired  to the GalN 
protocol.  Significant  differentiation  in the 2-AAF/PHx  protocol  is  typically  seen  between the 
1 l t h  and 14'h day after PHx. 2-AAF is metabolized into the cytotoxic/mitoinhibitory N- 
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hydroxy derivative by phase I metabolic enzymes in hepatocytes (Kroese et a/, 1990). 
Biliary  cells  and  oval  cells  express  very  low amounts of phase I and high  levels of phase II 
enzymes compared with hepatocytes, which favors detoxification over hepatocarcinogen 
activation in these cell types (Mathis et a/, 1989; Sirica et a/, 1990). By use of [3H] 
thymidine  labeling of  DNA  synthesis,  it  has  been  shown in vivo that 2-AAF alone  elicits  a 
mitogenic  response  in  ductal  and  nondescript  periductal  cells,  whereas  DNA  synthesis  in 
hepatocytes is blocked (Bisgaard et a/, 1996). The carcinogen exposure also induced 
expression of AFP, albumin and transcription factors which regulate their expression 
(Hepatocyte Nuclear Factor (HNF) l p  and HNF3y), reflecting the presence of oval cells 
within  the  population of induced  ductular  cells. 
Progression  through  cell  cycle  checkpoints  are  mainly  regulated  by the levels 
and  activities of different  cyclin/cyclin  dependent  kinase (Cdk) complexes. p53 (the  size of 
the  protein  is  53  kDa)  is  one of the  molecules  which  can  mediate G1 cell  cycle  arrest  by 
activation of Cdk inhibitor p27 synthesis (El-Deiry et a/, 1994). Cyclin/cdk complexes are 
also  known  to  be  involved  in p53mediated GI arrest  induced  by  TGF-P  (Ewen et a/, 1995), 
which  is  a  potent  inhibitor of hepatocyte  proliferation. It has recently been found  that p53 
expression  increases  in  response to 2-AAF treatment  (Ohlson et a/, 1998).  Cyclin  E/cdk2 
complex  formation  has  been  identified  as  critical  for Gl/S phase progression  as  it  enables 
transition to the S phase by  acting  as  histone  H1  kinase  (Dulic et a/, 1992).  It  was  further 
shown  by  Ohlson et a/ (1  998)  that  the  cell  cycle  related  increase  in  cdk2  is  not  seen  in  2- 
AAF treated rats. Finally, immunofluorescence studies have shown that cyclin E positive 
signals are restricted to oval cells, while hepatocytes remain negative (Trautwein et a/, 
1999).  These  studies  by  Ohlson et a/ (1998) and Trautwein et a/ (1999)  thereby  point  at 
two  molecular  explanations  for the 2-AAF mediated  inhibition of hepatocyte  proliferation; 
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Induction of p53  expression  resulting in elevated p27 expression  and  lack of cyclin  E  and 
cdk2  expression.  Both mechanisms arrest  hepatocytes in the GI phase. 
The combination of 2-AAF  treatment  with  PHx  results  in  a  dramatic  increase  in 
the expression of several growth factors when compared with 2-AAF treatment alone 
(Thorgeirsson et a/, 1993). The presence  of  these  growth  factors  appears to be essential 
for oval cell  survival.  2-AAF  treatment alone does  not  result  in  a  net  increase  of  oval  cells, 
as the number  of  apoptotic  NPCs  in  the  periportal  areas  also  increases,  thereby  retaining 
the  normal  liver  morphology  (Bisgaard et a/, 1996).  A  direct  mitogenic  effect of the  2-AAF 
metabolites on the hepatic ductal cell compartment  can  not  be  excluded,  but  he 
stimulation could also be mediated through the mitoinhibitory  effect  on  the  hepatocytes. 
The latter alternative might reflect a common mechanism in the 2-AAF/PHx and GalN 
protocols.  Despite their different mode of actions,  both of these  protocols  cause  situations 
of hepatocyte specific mitoinhibition combined with  a  liver  mass  reduction  which  provides  a 
growth  stimulus. 
1.6. A mitogenic effect of growth factors implies priming of target cells 
Whether regeneration  is  accomplished in response to PHx  treatment  or 
chemical  injury,  numerous  growth factors are  involved.  Among  these,  the  epidermal 
growth factor (EGF), the hepatocyte growth factor (HGF) and the transforming growth 
factor-cc  have been demonstrated  to  act as complete  mitogens  for  hepatocytes  in  culture 
and are considered to play very important roles in rat liver regeneration (Michalopoulos, 
1990). Direct infusion of these growth factors into the liver of normal rats does not, 
however,  cause  a  major  wave  of  DNA  synthesis  (Webber et a/, 1994;  Nagy et a/, 1996). A 
significant DNA synthesis  response  is obtained though, if  growth factor  infusion  is 
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preceded by: A 30 % PHx (which does not by itself induce a wave of DNA synthesis) 
(Webber et a/, 1994); collagenase treatment (a mixture of bacterially produced matrix 
metalloproteinases which perfuse the liver) (Liu et a/, 1994); or administration of 2-AAF 
(Nagy et a/, 1996), demonstrating that a priming stimulus must be provided in order to 
effectuate the mitogenic  potential of  growth  factors.  Within  minutes after PHx, the 
transcription  factor  Nuclear  factor  KB  (NF-KB)  is  transiently  activated  by  dimerization of the 
preexisting p50/NF-~Bl and p65/RelA subunits (FitzGerald et a/, 1995; Cressman et a/, 
1994). This activation  is  mediated  by  signaling  through  tumor  necrosis  factor  receptor  type 
1 (TNFR-l), as  demonstrated  by  PHx  in  TNFR-1  deficient  mice,  in  which  DNA  synthesis is 
severely  impaired  and  the  expected  increase  in  NF-KB  binding fail to occur  (Yamada et a/, 
1997). The NF-KB downstream  signaling  pathway  involves  transactivation of the  cytokine 
interleukin-6  (IL-6)  which  leads  to  increased  binding  of,  most  importantly, the transcription 
factor  signal  transducer  and  activator of transcription  protein  3  (STAT3).  Injection of IL-6 
in TNFR-1 deficient animals before PHx restores STAT3 binding to normal levels and 
corrects the DNA  synthesis  defect  (and  thereby  the  deficiency  in  regeneration),  but  it  does 
not effect the NF-KB binding (Yamada et a/, 1997). Similarly it has been shown, that 
disruption of the IL-6 gene in mice results in absence of STAT3 and impaired liver 
regeneration in the  PHx  model, a situation  which could be  reversed  by  a  single dose of IL- 
6  (Cressman et a/, 1996).  In  outline,  the  described  activation  events  result  in  sensitivity of 
the hepatocytes to the  effect of the  growth  factors,  which  enable the activation  cascade  of 
immediately  early  and  subsequently  delayed  early  genes  characterizing the G, phase to 
continue (Haber et a/, 1993; Taub, 1996). The above indications of the cytokine tumor 
necrosis factor-a (TNF-a),  as  the  initial  factor  acting  as  a  primer to sensitize  hepatocytes 
to the proliferation  effect of  growth  factors  have  recently  been  further  supported  by  Webber 
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et a/ (1998).  Infusion of  HGF and  TGF-a into the portal  vein of normal  rats in  concert  with 
TNF-a,  transiently  activated  NF-KB and STAT3 and increased the proliferative  response of 
hepatocytes to HGF  and TGF-a by  fourfold. Though the sequence of events  for  initiation of 
regeneration in the PHx protocol; TNF-a -+ TNFR-1 + NF-KB + IL-6 -+ STAT3 -+ 
remaining immediately early genes + delayed early genes + DNA synthesis, seems 
likely, it is not known whether TNF-a is the sole initiating factor in the PHx model of 
regeneration. The observation that regeneration is severely impaired in TNFR-1 deficient 
mice  may  indicate  that TNF-a is  one  among multiple factors  required,  though  these  are  not 
sufficient  by  themselves to elicit a full regenerative  response. The initial response  to  PHx 
by the release of preexisting  cytokines  like TNF-a  nd IL-6 from  Kupffer  cells 
(Michalopoulos  and  DeFrances,  1997) and the activation of transcription  factors  by 
posttranslational  modifications,  explain  the speed by  which the liver  responds  to  this  type 
of injury. Stimulation of cytokine production can be induced by various means, e.g. by 
endotoxin,  free  radicals or viruses  (Simpson et a/, 1997). The mechanism which  actually 
starts  the  process  in  response to PHx  (or  other  liver  injuries)  is,  however,  not  known. 
The regenerative response to PHx does not significantly involve oval cells. 
Transiently,  the  transcription of SCF, c-kit  and AFP  exceeds  detectable  levels,  but  there  is 
no  evidence  indicating  that  the  oval cells contribute  significantly to the  regeneration of the 
liver mass (Thorgeirsson et a/, 1994; Grisham and Thorgeirsson, 1996). It has been 
hypothesized  that  PHx  treatment  involves  activation of both  epatocytes  and the 
facultative  liver  stem  cells  (Thorgeirsson,  1996).  Incase of hepatocyte-specific 
mitoinhibition,  the  activation of the stem  cells and their  progeny  (oval  cells) are  sustained, 
and a similarly sustained expression of growth factors, including those known to be 
involved  in  response to PHx  treatment,  results  in the generation of the  differentiated  cell 
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lineages  needed  for  regeneration.  This  scenario may partly  explain the progress  in the 2- 
AAFlPHx protocol, but it certainly does not account for the mechanism which activates 
oval cells in the GalN protocol. On the contrary, the much faster response of oval cells 
seen in the GalN protocol  indicates,  that  a  mechanism  which  actively  primes  the  oval  cells 
for the proliferative  effect of growth  factors,  exists. 
TNF and IL-6 are also involved in regeneration from oval cells, but the data 
illustrating the  importance of the  cytokines  in  this  context  are  conflicting.  Dexamethasone 
is a well-known inhibitor of TNF and IL-6. In a study by Nagy et a/ (1998), the  effect of 
dexamethasone on rats exposed to PHx, 2-AAFIPHx and bile duct ligation (BDL) was 
examined.  Pretreatment  with  dexamethasone  suppressed  expression of both TNF  and IL- 
6 after PHx and significantly reduced the proliferative response of hepatocytes, but the 
failed response  could be rescued  by  IL-6  administration. Long term  dexamethasone 
treatment  prior to induction of oval  cells  by  the 2-AANPHx protocol  turned  out to be  lethal. 
If animals in the 2-AAF/PHx  protocol were  administrated  dexamethasone 24 hours  before 
they were killed, bromouracil (BrdU) positive oval cells decreased approximately 10 fold 
compaired to 2-AAFIPHx controls.  Dexamethasone  treatment  prior to  BDL  did not 
influence on the regenerative  response  and  it was  concluded  that  dexamethasone 
effectively  inhibits the proliferative  response of hepatocytes  and  oval  cells,  but  not bile duct 
cells.  However,  a  possible  synergistic  effect of 2-AAF and  dexamethasone  was  not 
examined, e.g.  by a  2-AAF/dexamethasone/BDL  experiment or  rescue  of 2- 
AAF/dexamethasone/PHx treated animals by IL-6 administration. In a recent study by 
Rosenberg et a/ (2000),  the  regeneration  from  periportal  liver  injury  induced  by 
phenobarbital feeding and cocaine  injection  (induce  proliferation of hepatocytes in middle 
and central  zones  and  proliferation of intraportal  oval  cells)  was  examined  in  normal and 
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IL-6 knockout mice. It was demonstrated that IL-6 knockout mice compensated for a 
reduced hepatocyte proliferation by increased oval cell proliferation, resulting in timely 
repair of the  liver  injury.  These  results  show  that IL-6 differently  influences  on  the 
proliferative  capacity of hepatocytes and oval  cells. 
Our  present  knowledge  regarding  mechanisms for priming of oval cells is  clearly 
insufficient.  The  fact  that  oval  cells  do  not  contribute to regeneration from PHx  treatment 
could  reflect  that  additional  priming  mechanisms/factors  are  necessary in order to activate 
oval  cells.  Recruitment of  such  factors  could be controlled by hepatocytes,  and if so, only 
in  situations of  compromised  proliferative  capacity  of  hepatocytes. The liver could thereby 
ensure  that  the  slower  process of regeneration  from cell types incapable of immediately 
conducting  liver  cell  functions  are  only  activated  in  emergency  situations. 
1.7. Growth  factors  involved  in  regeneration from oval cells. 
Due to the tremendous  regenerative  capacity and the  existence of a simple 
and  well  functioning  experimental  approach  (PHx), the regenerating  liver has been  widely 
used to identify  and  study  the  role of growth  modulators in regeneration.  Several  important 
factors  involved in regeneration  from  PHx  treatment  have  been  characterized 
(Michalopoulos  and  DeFrances,  1997), but the high degree of redundancy and pleiotrophic 
effects of many of these factors  have  complicated the elucidation of their  functions  and 
how  the  complex  interplay  between  them  is  organized and controlled.  Expression-analysis 
of cytokines,  growth  factors  and  their  respective  receptors in the context of regeneration 
from  oval  cells  in the 2-AAF/PHx  model,  has  been performed for acidic  fibroblast  growth 
factor  (aFGF),  leukemia  inhibitory  factor (LIF), TGF-a,  EGF, and SCF as well as HGF and 
the urokinase-type plasminogen activator (uPA), urokinase-type plasminogen activator 
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receptor  (uPAR),  plasminogen  activator inhibitor-l (PAI-l) system  which  is  involved  in  the 
release,  conversion and regulation of pro-HGF to its active  form  (Marsden  et a/, 1992; Hu 
et a/, 1995;  Evarts et a/, 1993; Omori et a/, 1996;  Evarts et a/, 1992;  Nagy et a/, 1996;  Fujio 
et a/, 1994;  Hu et a/, 1993;  Bisgaard et a/, 1998). 
The proliferative activity in the 2-AAF/PHx protocol is concentrated on oval 
cells  (and Ito cells) and this is in  accordance  with  the  general  picture  which  emerges  from 
the study of growth modulators and their receptors. Whereas the activity of growth 
modulators  in  response to PHx  treatment  (at  least  in  the  initial  phase)  mostly  expands  from 
hepatocytes (and Ito cells), and are directed towards hepatocytes, this activity pattern 
changes  in the 2-AAF/PHx  protocol,  in  which  growth  modulators  mostly  are  expressed  by 
oval cells and Ito cells and  are  directed  towards  oval  cells.  Studies of SCF,  LIF  and  HGF 
have identified especially  interesting  individual  characteristics  as  described  in the 
following. 
SCF was  originally  identified  as an important  hematopoietic  cytokine  (Zsebo et 
a/, 1990). SCF and its receptor c-kit are expressed in fetal iver, which is a site of 
hematopoiesis  during fetal life, but the transcripts  are  not  detected  in  adult  liver  (Fujio  et a\, 
1994). They differ  from the remaining  factors  mentioned  above,  as  their  expression  does 
not increase  significantly  in  response to PHx  treatment.  Expression of  SCF and its 
receptor c-kit is, however, dramatically induced in response to the 2-AAF/PHx protocol 
(Fujio et a/, 1994). Expression of mRNA for both ligand and receptor increased from 12 
hours after the partial hepatectomy with  a peak of  SCF  at day 4, and  with a more  gradual 
increase of c-kit transcripts, which stayed elevated until a large portion of the oval cells 
started to differentiate. The SCF  transcripts  were  expressed  by  oval cells and Ito cells but 
transcripts  for  the c-kit receptor  were  restricted to oval  cells.  The  induction of SCF and  c-kit 
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shortly  after the liver  mass  reduction  by  PHx  in  the  2-AAF/PHx protocol may  reflect  a  role 
of this cytokine system in the early development of oval cells. This has been further 
indicated in a  recent  study  by  Matsusaka et a/ (1  999).  The  role  of c-kit in the 2-AAF/PHx 
protocol was examined by use of WsiWs rats, whose c-kit tyrosine kinase activity was 
severely  impaired  owing to a  deletion  in  the  kinase  domain.  Compared to normal rats,  the 
development of oval cells was significantly suppressed at day 7, 9 and 13 after PHx. 
However,  the  expression of oval  cell  markers  and  the  proliferative  activity  was  detected at 
equal evels in WsNVs and normal rats, indicating that the receptor mediated signal 
transduction  only  plays  a  minor  role  in  determining  the  phenotype and in the proliferative 
activity of oval  cells. 
LIF is  a  polyfunctional  cytokine  with  several  biological  characteristics  similar to 
TNF, IL-l and IL-6 (Gearing,  1993;  Hilton  and  Gough,  1991;  Kurzrock et a/, 1991). 
Receptors for  LIF (LIFR)  exist  in  low-  and  high-affinity  forms and conversion to the latter 
form  is conferred by  the  signal  tranducing  subunit gpl30, which LIF shares with IL-6 type 
cytokines,  reflecting  a  functional  redundancy  (Kishimoto et a/, 1995). For the 
LIF/LIFR/gpl30 system, a phenotypic difference between hepatocytes and oval cells in 
their  signaling  through  gp130  has  been  indicated.  A well  described  response of 
hepatocytes exposed to LIF is the expression of acute phase proteins. By separation of 
parenchymal and nonparenchymal cells combined with in situ hybridrization analysis, 
Omori et a/ (1996)  showed  that al-acidglycoprotein (al-AGP) (representing acute phase 
proteins) expression was restricted to hepatocytes in the 2-AAF/PHx protocol. The LIF, 
LIFR and gp130 transcripts were mainly found in nonparenchymal cells, including oval 
cells. These observations indicate that the function of the LIF/LIFR/gpl30 system differ 
significantly  between  hepatocytes  and  oval  cells. 
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HGF  was originally  identified  in  the  serum of rats  exposed to PHx  treatment  as 
a  potent  mitogen  for  normal  hepatocytes in culture  (Michalopoulos  et  a\,  1984;  Nakamura 
et a/, 1984),  but  has  also  been  recognized  as  a  motogen  as  well  as  a  morphogen  factor 
(see Naldini et a/ (1995) for references). The receptor for HGF is c-met (Naldini et a/, 
1991),  which,  like  several  other  growth factor receptors, e.g.  EGFR  and  the  receptors for 
aFGF, transduce its signal through a tyrosine kinase activity. In the liver, HGF is not 
produced  by  hepatocytes,  but  by nonparenchymal sinusoid-lining  cells,  principally  Ito  cells. 
The HGF  transcript  is  expressed  in  low  levels  in  normal  liver  (Hu et a/, 1993),  but  the  level 
increases dramatically in response to PHx treatment,  starting from 3-6 hours after PHx, 
and  peaks  at 12 hours after PHx  (Zarnegar et a/, 1991). The increase of  HGF  in plasma of 
rats  exposed  to  liver  injuries  (PHx and CCI4  administration)  is  even  faster,  with  a  peak of 
17 fold  increase  just 2 hours  after  PHx  (Lindroos et a/, 1991).  In  the  2-AAF/PHx  protocol, 
an  increase  in  the  HGF  transcript  level  is  seen  1 day after PHx,  with  a  peak  at  day 6 and  a 
decrease  after  day  13 (Hu et a/, 1993). c-met expression  also  increased  gradually  with  a 
peak  around  day  9 to 13. In situ hybridization  further  showed  that the HGF  transcripts  were 
localized in Ito cells, whereas the transcript for c-met were strongly expressed by oval 
cells,  indicating  that  the HGFlc-met system functions  by  a  paracrine  mechanism.  Hu et a/ 
(1993) did not observe an increase in HGF and c-met transcripts in response to 2-AAF 
treatment  alone.  HGF  is  secreted  as an inactive  single-chain  precursor  (pro-HGF),  which 
binds to the  cell  surface  or the ECM,  presumably  via its affinity  for  heparin-like 
glycoaminoglycans, and it  also  binds to the c-met receptor,  but  without  triggering  its  kinase 
activity  (Naldini et a/, 1995).  Conversion  of pro-HGF to an active  heterodimeric  molecule 
requires  proteolytic  activity, a process  which  takes  place in the extracellular  environment. 
Plasminogen activators (PAS) and inhibitors (PAIS) are thought to be key participants in 
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the balance of proteolytic and antiproteolytic  activities  that  regulate  matrix turnover 
(Vassalli et a/,1991). In the  liver  exposed  to PHx treatment,  de novo appearance  of  active 
uPA and uPAR in homogenates  has  been  documented as early  as  1  minute  after  surgery 
(Mars et a/, 1995).  Western blot analysis  and  zymography  further  showed  that  the  resulting 
enhanced  activity of  uPA  was  mainly  due  to  a  dramatic  increase in uPAR  expression.  uPA 
appeared to be the primary agent that  activated  pro-HGF, as cleavage could be prevented 
by antibody  against  uPA. In studies using  tissue  cultures it has  been  shown  that  activation 
of pro-HGF  involves  the  formation of  a stable  complex  between  pro-HGF  and  uPA  bound 
to  the  c-met receptor  (Naldini et a/, 1995).  By  use  of  immunohistochemistry,  Northern  blot 
analysis and  zymography  Bisgaard et a/ (1998)  established,  that the plasminogen 
activator/plasmin system is also involved in regeneration in the 2-AAF/PHx protocol. 
Plasminogen  activation  was  located  over  the  expanding  oval  cell  population, but not over 
the mitoinhibited  mature  hepatocytes,  thereby  providing  an  effective  mechanism by which 
HGF activation can be  specifically  targeted  to  the oval cell  surface. A summary  of oval cell 
growth modulating  molecules are shown  in  Figure 3. 
1.8. The extracellular matrix and the  local  microenvironment 
The bile duct  structures  in  the  portal  tracts  are  surrounded by matrix 
components  which  form  a  classic  basement  membrane,  containing  type  IV  collagen and 
laminin,  and  which are associated  with  the  cholangiocytes  and the adjacent  hepatocytes 
too. The ECM  gradually  changes  across  the  liver  acinus and the  basal  lamina  is  replaced 
with components such as fibrillar collagens and fibronectin (Martinez-Hernandez and 
Amenta, 1993). The plasminogen  activator/plasmin  cascade  is  involved  in  degradation of 
type IV collagen and fibronectin  (Gold et a/, 1992;  MacKay et a/, 1990) and may thereby 
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Figure 3. Schematic  representation of positive regulators of oval cell proliferation operating through 
paracrine and/or autocrine loops. aFGF: acidic fibroblast growth factor; EGFR: epidermal growth factor 
receptor; HGF: hepatocyte growth factor; IL-6: interleukin 6; LIF: leukemia inhibitor factor; LIFR: leukemia 
inhibitor  factor  receptor; SCF: stem cell factor; TGF-a: transforming growth  factor-a;TNF-a:  tumor  neucrosis 
factor-a; TNFR-1: tumor neucrosis factor receptor-l; uPA: urokinase-type plasminogen activator: uPAR: 
urokinase-type  plasminogen  activator  receptor.  Redrawn  and modified from Alison (1998). 
assist in the migration of oval  cells into the parenchyma. Further, the  matrix  degradation 
may  not  only result in  the  release of pro-HGF, but also matrix bound TGF-P and  possible 
EGF  (Bisgaard et a/, 1998;  St  Hilaire et a/, 1983; Burwen et a/, 1984). The injury  cased  by 
GalN, and the regenerative response caused by PHx, is diffuse throughout the entire 
hepatic lobule, whereas damage caused by CC14 and AA is limited to centrilobular and 
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periportal regions, respectively. To examine the relationship between the site of lobular 
damage and  the induction of oval cell proliferation,  Petersen et a/ (1 998 b)  compaired  the 
regenerative  responses to CC14, AA  or  PHx  when  combined  with  2-AAF. It was  found  that 
the  oval cell response to 2-AAF/AA  treatment  was  ignificantly  smaller  than the 
corresponding  response to 2-AAF/PHx and 2-AAFICCL treatment.  Conversely, the 
proliferative  response of intraportal  bile  duct  epithelia  was  most  intense in the  2-AAF/AA 
model.  As  the  AA induced death of hepatocytes  is  likely  to  have  effects on the  connective 
tissue  matrix of the  periportal  sites,  the  results  uggest  that  the  periportal  matrix 
contributes  significantly to the stimulation of oval cell activities. 
1.9. Aims of the present  study 
The studies of regeneration from oval cells performed so far illustrate several 
aspects in which the process differs from ordinary  liver  regeneration  based  on  mature  cell 
populations.  These  differences  include  alterations  in  the  networks of autocrine and 
paracrine mechanisms which stimulate the involved cells, and the presence of factors 
associated  with  regeneration from oval  cells  only.  The  number of molecules  identified as 
associated  with the oval cell  response, and consequently  our  understanding of the 
mechanisms  involved,  is,  however,  rather  limited. In order  to  increase  our  understanding  of 
the  mechanisms  which  control  the  activation,  proliferation,  migration and differentiation of 
oval  cells,  the  following aims were  defined for the present  study: 
To start a mapping of genes that are highly expressed when oval cells are activated 
and recruited for liver  regeneration. 
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Characterize the roles of the identified gene products by analyzing the expression of 
the genes  themselves and possible  associated  molecules. 
Two different  experimental  approaches  were  used to identify  genes  associated  with 
regeneration  from  oval  cells: i) Suppression  subtractive  hybridization (SSH) analysis and ii) 
Signal  peptide  selection  (SPS)  combined  with  Northern  blot  analysis.  For  both 
approaches, the 2-AAF/PHx protocol was used to induce a regenerative response from 
oval cells. SSH analysis  selects for differentially  expressed  genes  at the cDNA  level,  that 
is, irrespective to the functional properties of the corresponding products. Consequently, 
this  approach  identifies  products of differentially  expressed  genes  which  are  present  at all 
the cellular  levels  by  which  the  oval  cell  associated  response is characterized.  Contrary, 
the SPS method selects for genes encoding secreted and membrane-bound molecules. 
This subgroup of molecules  includes  the  growth  modulators and receptors  which  regulate 
the actions of individual  cells  with  respect to a  regenerative  response. The SPS method 
was introduced in the present study with the aim to focus on the category of secreted 
regulating  molecules. 
32 
2. Materials and methods 
Besides the materials and methods described in Paper I & 11, the following  experimental 
procedures  were used in this study: 
Preparation of the h-RKl8 vector 
The  h-RK18 phage  was  amplified in E. coli strain BB4 (LE392.23 
[F'Lac~ZAM75proABTn70(Tetr)]) as described by Sambrook et al. (1989). h-RK18 DNA 
was purified by use of the QIAGENB Lambda Maxi kit according to the manufacturers 
instructions, except for the addition of a Proteinase K (50 pg/ml - approx. 20 U/pg) 
(BOEHRINGER  MANNHEIM,  Germany)  treatment  step  by  incubation at 56% for 1  hour in 
10 mM Tris (pH 7.6), 5 mM EDTA, 0.5% SDS, prior the column purification step. To 
prepare the h-RKl8 vector for cloning of  cDNA in the  unique Not I site, lambda cohesive 
ends were ligated followed by Not I digestion and dephosphorylation,  essentially as 
described by Sambrook et al. (1989). The effect of the  individual  treatments was verified 
by  comparative  examination of infection  efficiency.  Obtained  reductions  were  2  x  1 0-3 and 
5.5 x 10" for ligated versus ligated/Not I treated and  ligated/Not I treated  versus 
ligated/Not I/dephosphorylated aliquots, respectively, and thereby within the described 
ranges for successful manipulations.  Optimal h-RKl8:cDNA ratio  was  determined  by  trial 
ligations as described by Sambrook et al. (1989). Phage DNA was packed by use of 
GigaPack 111 Gold (Stratagene, La Jolla, CA) according to manufacturers instructions 
except for the termination volume, which was reduced to 1/10, in order to obtain a 
concentration of plaque forming units that made it possible to use the primary (non- 
amplified) phage library directly  in phagemid excision  reactions. 
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Construction of the hRKl8/PAI-l positive  control. 
The 405 bp 5’ PAI-l sequence used to verify the functionality of the SPS 
method in our  laboratory  was  prepared by PCR  on full length PAI-l in a  pCR2.1 
(Invitrogen Corp., Carlsbad,CA) vector background (from Dr. Hanne Cathrine Bisgaard). 
Primers for PCR amplification and introduction of Not I cloning sites were forward 5’ - 
gcggccgcggcacttccgaaagctccag- 3’ and reverse 5’ -gcggccgctggcgtccgcagt-actgatctc- 3’. 
The PCR  reaction  mixture  was  composed as follows: I x  PCR  buffer  (Perkin  Elmer  Corp., 
Norwalk, Connecticut), 200 FM each dNTP, 10 pmole  each  forward and reverse  primers, 
2.5 U Ampli  Taq  polymerase  (Perkin  Elmer  Corp.) and amplified in 30 cycles of 94°C for 
30 seconds,  55°C  for 30 seconds and 72°C for 30 seconds. The amplification  product  was 
subsequently ligated into pCR2.1 (Invitrogen) and plasmid DNA amplified in E. coli. The 
PAI-l Not I fragment  was  obtained  by Not I digestion and purification from agarose  gel and 
ligated into X-RK18. Correct orientation and in-frame cloning was verified by sequence 
determination of the  cDNA  insert  from  a  sucrose  positive YT455 PAI-l yeast  transforrnant 
as  described  in  paper II. 
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3. Primary  experimental  approaches 
3.1. Identification of genes associated with  regeneration  from oval cells by 
Suppression  Subtractive  Hybridization. 
The Suppression Subtractive Hybridization method (SSH) used in this study 
(CLONTECH  PCR-SelectTM  cDNA  subtraction,  Clontech  Laboratories  Inc.,  Palo Alo, CA)  is 
based on the principles of traditional  subtractive  hybridization, in which two mRNA 
populations (converted to cDNA) are compared by the use of one of the populations 
(called driver cDNA) as a reference in hybridization reactions. This subtraction makes it 
possible  to  isolate  sequences  which  are  expressed in only  one of the  populations  (refered 
to as  the  tester  cDNA). In addition to this  basic  concept, the PCR-SelectTM  method  uses  a 
hybridization  strategy  which  levels the concentration of high and low  abundance 
sequences and a  subsequent  PCR  amplification  increases  the  sensitivity for detection of 
differentially  expressed  sequences. 
In the present study, mRNA from the nonparenchymal cell (NPC) population 
at day 7 in  the  2-AAF/PHx protocol was  used to construct the tester  cDNA  population  and 
mRNA from the NPC population of normal rats were used to construct the driver cDNA 
population. Although hepatocytes may be involved in generating the oval cell response, 
use of the NPC populations aimed the identification of differentially expressed genes 
towards  the cell fraction  which  include the oval cell population.  At  day 7 in  the  2-AAF/PHx 
protocol,  no  overt  differentiation of oval cells  is seen (see  Paper l). Use of  NCP 
populations from day 7 thereby selected for the identification of differentially expressed 
genes  involved in the  activation and proliferation of oval cells rather  than  differentiation. 
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3.1 .l. The  molecular basis of Suppression  Subtractive  Hybridization 
In practice, the PCR SelectTM procedure  implicates the following events 
(depicted in Figure 4): The two mRNA populations are converted into cDNA and further 
modified into short blunt-end sequences  by  digestion  with the four base cutter Rsal. The 
cDNA  representing  the  material  under  examination  (the  tester  cDNA)  is  then divided into 
two aliqouts which are ligated with adaptor 1 or 2, respectively. These adaptors do not 
have a phosphate group and consequently  only  one  strand of each adaptor attaches to the 
5’ end of the cDNA. The tester cDNA aliqouts are then separately hybridized with the 
second cDNA  population  (the  driver  cDNA),  giving  rise to molecules  of the following  types 
(Figure 4): 
a; Single stranded cDNAs present in the tester population only. The concentration of 
low and high abundance sequences is leveled as high abundance molecules re-anneal 
and form type b hybrids. 
b; Double stranded  cDNAs of high abundance sequences  from  the tester population. 
c; tester + driver  hybrids of cDNAs  present in both populations. 
d; single and double  stranded  cDNAs  representing  low  and high abundance molecules 
present  in the driver  population  only. 
The two hybridization reactions are subsequently mixed, without prior denaturation, 
resulting in the formation of type e hybrids, composed of double  stranded  subtracted 
cDNAs with different ends. Type e molecules are further enriched by addition of a new - 
aliquot  denatured  driver  cDNA. 
The ends are then filled in  by DNA polymerase,  resulting  in differentially expressed tester 
sequences (e type molecules) with different  adaptor  sequences in their 5’ and 3’ ends. 
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Figure 4. The molecular events of PCR-Select cDNA subtraction. Redrawn and modified from CLONTECH 
manual  #PT1 11 7-1, 
Finally the entire reaction is subjected to PCR amplification. Only the differentially 
expressed tester cDNAs (type e) are exponentially amplified as type a and d molecules 
lack primer annealing sites and type c molecules  are  amplified in a linear fashion as primer 
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annealing sites are present in only one end. Type b molecules are potential targets for 
PCR amplification but this reaction is efficiently suppressed due to the adaptor design. 
Each of the two adaptor  types are self-complimentary,  resulting  in  the  formation of pan-like 
secondary structures of type b molecules in favour of primer annealing during the PCR 
cycle annealing  step. 
3.1.2. Clones  identified  from  the 2-AAWPHx day 7 NPC  population  by  use of SSH 
analysis 
In the present  study,  the  secondary  SSH  PCR  reaction  was  used  directly  for 
cloning of differentially  expressed  sequences  by  use of the T/A  vector  pCR2.1  (Invitrogen 
Corp.,  Carlsbad, CA). The  identity of the  cDNA  inserts  from  119  clones  was  revealed  by 
sequence  analysis and comparison to known DNA or  amino  acid  sequences or expressed 
sequence  tags (ESTs) using the BLAST  algorithm (httu://www.ncbi.nlm.nih.eov/BLAST/). Twenty- 
nine known and five  novel  unique  cDNA  sequences in addition to four ESTs were 
identified as shown in Table 2. 
As a SSH cDNA library is likely to contain false positives, the differential 
expression of identified  genes  must  be  confirmed  by  expression  analysis. In the  context of 
this thesis,  eight of the known  genes;  lnterleukin  1-p (IL-lp), a-fetoprotein  (AFP),  ebnerin, 
eukaryotic initiation factor 67 kDa associated protein, interferon-y receptor a (IFN-*a), 
gpglphox, lymphocyte function-associated molecule-l a (LFA-1) and CXCR4 (Table 2, 
written in bold), were further analyzed by Northern blot analysis and all found to be 
differentially expressed. The calreticulin, PRxV and Hex sequences have subsequently 
been examined but differential expression was not detected for either of these genes 
(Bisgaard, unpublished results) As described in Paper II, the chemoattractant receptor 
CXCR4 is induced when oval progenitor cells are activated and might be a central 
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component in a pathway which brings about oval cell activity-associated T-lymphocyte 
recruitment. The remaining seven examined genes are all parts of the gene network 
connected  to  Interferon y and  are  modulated in regeneration  from oval progenitor  cells, as 
described  in  Paper I. The possible  implications of the eight  differentially  expressed  genes 
in oval  progenitor  cell  activity  will not be  paid  any  further  attention in this  chapter, but are 
thoroughly  examined  in  chapter 4, Paper I and II. 
Table 2. Unique  clones  identified from the suppresion subtractive hybridization  library using non- 
parenchymal cell populations  from  a  Z-AAF/PHx  treated  rat  day  7 as tester cDNA  and  nonparenchymal cell 
populations from a  normal  (control)  rat as driver  cDNA.  Genes  written  in bold were  further  analyzed  in  Paper 
I or  Paper II. 
Gene name  Remarks ACC noJReferences 
High mobilitygroup non-histone  chromosomal  protein NM-008251.  Landsman  and 
protein 14 Bustin.ll990) 
A tp la l  NM-012504. Shull etal. (1986) ATPase,  Na+K+ transporting,  alpha  1  polypeptide 
1 protein 
l 1 
CllDBP 1 DNA-binding  protein:  high  mobility  group  1 protein 1 L08814. Wancl etal. (1993) 
1 homologue . -  . . - 
KIM0235 protein 1 Novel gene isolated from male bone marrow I D87078. Naaase et al. (1996) 
(H.  sapiens) 
Interleukin-l,L3 
myeloblast cell line KG-l 
phages. IL-lp binds  to IL-lR1 and  induces  trans- 
M98820.  Unpublished:  Schroeder Inflammatory  cytokine  released from macro- 
et al. (1998) 
I 
(IL-IB) 
CXCR-4 (murine) D87747.  Nagasawa et al. (1  996) PBSF/SDF-1  receptor.  Involved in liver regene- 
1 cription  and  translation if IFN-y  in  hepatocytes. 
ration  from  oval  progenitor  cells  (Muller et a/. 
submitted to AJP) 
production  (Yamashita et a/. 1994) 
cells.  (Bisgaard et al.  in  preparation) 
(1981) 
Alpha-fetoprotein 
@FP) 
Oval  progenitor cell marker. Suppresses IFN-y NM-01  2493. Jagodzinski et al. 
Ebnerin Involved  in  liver  regeneration from oval  progenitor U32681. Li and Snyder.  (1  995) 
Eukaryotic  initia- L10652. Wu  etal. (1993);  Kumar  Protects elF-2 from  inhibitory  phosphorylation by 
tion factor (€if-2) IFN-y  induced elF-2 kinases et al. (1  997) 
67 kDa asso- 
ciated protein 
Interferon-y 
receptor (Y (IFN- properties  towards IFN-.( (Arany et a/, 1998) 
Cell  surface  receptor  which  exhibits  ligand binding AF201  901. Direct submission 
1999 
yRa) 
ATPase  domain 
Conserved 
orofein of 44kDa 
U36395.  Bauer et al. (1  996) A  regulatory  subunit of the 26s Proteasome. 
~~ 
(CADp44) (S. 
sid23p (murine)  Actin  depolymerizing  factor,  AB025406. Direct submission 
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Gene name l Remarks 
adenylate synthe- dendritic cells. 
54 kDa oligo- induced during maturation of murine 
tase-like protein 
p54OASL (murine) 1 
Calreticulin 1 Lectin-like chaDerone  which  DarticiDates  in  the 
synthesis of several  molecules including surface 
receptors and integrins (Michalak  M et al. 1999). 
Not specifically  associated  with  oval cell activity 
abha B2/Man2b2) 
(murine) ' 
PRx IV Peroxidins play    role in protecting protein free 
thiol groups  against  oxidative damage and 
thioredoxin-dependent peroxidase  activity. PRxlV 
is a secretory form which  functions within the 
extracellular space. Not specifically  associated  with 
oval cell activity  (Bisgaard  unpublished  result) 
F-0-ATPase Precursor of subunit  b  in  H+-ATP  synthase  from 
subunit b mitochondria 
F-box protein FBL4 Member of the expanding  F-box protein family. F- 
(H. sapiens) box proteins are one of the  four subunits of 
Rap l B 
Putative secreted Function unknown. 
ubiquitin protein ligases (Cenciarelli etal. 1999) 
Ras homologous  GTPase implicated in cell 
proliferation and  differentiation (Posern et al.  1998) 
protein  ZSIG37 
(murine) 
gp9iphox (Cybb) Heavy chain of cytochrome  b558. Induced as a 
(murine) primary response  g ne by IFN-y (Eklund and 
Hex 
1 Skalnik.  (1995) 
Homeobox  gene.  Trancriptional  regulator.  Not 
specifically associated with oval cell activity 
Lymphocyte 
1 (Bisgaard unpublished  result) 
1 Lymphocyte  adhesion  receptor.  Regulated  in 
fUnCtiOn-aSSOCi- responseto IFN-y, Binds ICAM-l and ICAM-2, 
ated molecule-l a which are induced as secondary response genes 
subunit (LFA- by IFN-y.  (Barker et al.  1989). 
l)(murine) 
Ribosomal proteins Ribosome subunits 
L3,  L4,  L6,  L12  and 
s7. 
SSH clone G6 EST292485 from normalized rat liver 
SSH clone  41  EST189325 from normalized rat heart 
SSH clone 11  2 
SSH clone 85 EST va73d09.rl Mouse  cDNA 
EST294771 from normalized rat embryo 
Five  novel  unique 
cDNA sequences 
Ace nomeferences 
AF068835.  Tiefenthaler et al. 
(1 999) 
X53363. Murthy et al.  (1990) 
NM-008550. Hiramoto et al. 
(1 997) 
AF1  06945. Matsumoto et al. 
(1 999) 
M35052.  Tsurumi etal. (1990) 
AFl99420. Direct submission 
1999 
U07795. Direct submission. 1994 
AF192499. Direct submission. 
2000 
U43384. Bjorgvinsdottir  H et al. 
(1  996) 
D86383. Tanaka T et al. (1 999) 
M60778. Kaufmann etal. (1991) 
X62166,  X82180,  X87107, 
X53504,  X53377,  respectively. 
AW 142249 
AA799828 
AA272079 
AW913993 
Table 2. continued. 
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3.2. Identification of genes  encoding  secreted  and  membrane-bound  proteins 
associated  with  regeneration  from  oval  progenitor  cells.  Combination of The  Signal 
Peptide  Selection (SPS) method  and  expression  analysis. 
Virtually all proteins which are secreted or bound in the cell membrane of 
prokaryotes as  well  as  eukaryotes  are  characterized  by  the  presence of a provisional N- 
terminal sequence, a signal peptide, which controls their entry to  the secretory pathway 
(Gierasch, 1989; von Heijne, 1990; Rapoport, 1992). Common to the structure of signal 
peptides is a positively charged n-region, followed by a hydrophobic h-region and a c- 
region in which the residues  at  position -3 and -1 must be small  and neutral for cleavage 
to occur correctly (von  Heijne,  1985).  These  features  can  be identified in the signal peptide 
of most known secreted proteins but the level of degeneracy within any one of these 
structural elements is rather  high.  Therefore,  it  is  not  possible to identify novel extracellular 
proteins by  use of standardized  signal  peptide  encoding  cDNA probes or DNA database 
searches using  e.g.  expressed  sequence  tags.  Consequently, in  vivo methods were 
developed to select for secreted proteins (Tashiro et a/, 1993; Klein et a/, 1996; and 
variations of these e.g.  Lim and Garzino-Demo, 2000; Jacobs et a/, 1997).  These methods 
all identify signal peptide encoding cDNAs based on their ability to complement for a 
deleted signal peptide encoding  sequence of a naturally secreted gene  product.  An in  vitro 
method based on sedimentation  velocity of  mRNA species  bound to membrane- 
associated polysomes and subsequent hybridization to DNA microarrays has just been 
introduced (Diehn et al. 2000) 
When the present study was initiated the Signal Peptide Selection (SPS) 
method (Klein et al., 1996)  appeared as the  most  suitable,  as it has integrated a selection 
step  and allows simultaneous examination of millions of cDNA clones (see below). The 
capacity of the method  developed  by Tashiro et a/. (1993) is much  smaller  as it requires a 
subsequent antibody based screening step, which makes this method unsuitable for 
examination of large amounts of cDNAs. 
3.2.1. The Signal Peptide  Selection  method 
The method to isolate  genes  encoding secreted and  membrane-bound 
proteins developed by Klein et a/. (1996) is based on a single-step selection in yeast. It 
takes advantage of the fact that the ability of Saccharomyces cerevisiae to grow on a 
sucrose medium depends on the secretion of the SUC2 encoded  invertase  enzyme,  which 
catalyze the breakdown of sucrose into glucose and fructose (Figure 5, B). A library 
representing the cDNA  of  interest is established as Not I fragments  in a  h-based shuttle 
vector, upstream a modified suc2 gene, from which the sequence encoding the signal 
peptide and the initiator methionine is deleted (sucpMSP) (Figure 5, A). The  cDNA/ 
sucpMSP constructs are subsequently converted to an Ecolilyeast plasmid library and 
introduced into  a SUC2 deleted yeast strain. To  select  for  signal  peptide  encoding  cDNAs 
cloned in-frame with the sucpMSP gene,  yeast  transformants  are  finally  replicated onto a 
sucrose medium. 
Only 0.6% of the wild-type invertase activity is sufficient to allow growth on sucrose 
medium (Kaiser et al, 1987), why even inefficient heterologous (e.g. mammalian) signal 
peptides are able  to direct an invertase fusion protein  to  the  secretory  pathway.  Klein et al 
(1996) demonstrated the potential of the SPS method by examining five cDNA libraries 
representing human bone marrow,  whole  rat  embryo,  rat  embryonic  brain  or  specific parts 
of embryonic rat brain. From a total of = 20 million yeast transformants, 49 sucrose 
positive clones were found  to contain unique cDNAs encoding known proteins localized 
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Figure 5. The Signal  Peptide  Selection  method. A) Schematic  representation of the  h-based E. coli/yeast 
shuttle-vector  for  cloning of cDNAs  upstream  the  modified invertase gene lacking the initiator methionine  and 
the  signal  peptide ( s u c ~ ~ ~ ~ ) .  Asterisks  represent the initiator and terminator sites for f l  DNA  synthesis  and 
define  the  boundaries of the sequence  excised  as  phagemid. This sequence include  genes  for selection of 
transformants and replication in E. coli and yeast, respectively. B) Schematic representation of the SPS 
method. The panels  indicate  the  ability of the yeast  strain "T455 to grow on sucrose when  the SUCZ gene is 
present in pRK18 as a wild type copy, MSP truncated, includes the first 46 amino acids of the secreted 
transforming  growth factor p in the MSP truncated  pRK18  version  or  when fused to a  random collection of 
cDNAs,  respectively.  Redrawn  and  modified from Klein  et  al.  (1996). 
along  the  secretory  pathway  or  exported to the cell surface or  the  xtracellular 
environment. Another 17 cDNAs were related to known proteins which belonged to the 
same categories of destinations. Finally, 74 unique clones representing unknown genes 
were  by  computer  analysis  found to contain  possible signal peptide encoding  sequences. 
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The known cDNAs included sequences encoding: members of the transforming growth 
factor and epidermal growth factor families, endocrine hormones, tyrosine- and serine/ 
threonine kinase receptors, cell adhesion molecules, extracellular matrix proteins and 
plasma proteins. 
3.2.2.  Construction of a hRKl8/PAI-1 positive  control 
In order to verify the functionality of the SPS method in our laboratory, a 
positive  control  was  constructed. A 405 bp fragment,  encoding  the 23 amino acid signal 
peptide sequence and the first 99 amino acids of the structural  gene  from  the  secreted  rat 
serine protease inhibitor, Plasminogen activator inhibitor-l (PAI-l) (Zeheb and Gelehrter, 
1988), was cloned in-frame with the ~ u c ~ ~ ~ ~  gene. Replication of YT455 pRKl8/PAI-l 
transformants to sucrose plates resulted in positives  after  incubation  for 2-3 days.  Parallel 
examination of m455 pRKl8-insert transformants did not result in growth on sucrose 
plates even after 4 weeks of incubation. 
3.2.3.  Examination of a  2-AAFIPHx  cDNA  library  by  SPS  analysis 
Selection of cDNAs by SPS analysis  is  solely based on the functional 
properties of the examined sequences.  As  no  subtraction  or  leveling  steps  are  included  in 
the method, highly expressed cDNAs which are able to complement for the truncated 
sucrose  gene sequence will naturally constitute the preferential output. In order to increase 
the possibility of identifying molecules associated with regeneration from oval progenitor 
cells,  cDNA from day 11 in the 2-AAF/PHx  protocol was examined. At this  time  point  the 
presence of progenitor cells was massive according to histological  evaluation  (See  Figure 
1 Paper 11). 
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A total of 6 x lo6  non-amplified hRKl8/2-AAF/PHx cDNA plaque forming units 
(pfu) were excised in pools of lo5 pfu. To verify efficient ligation of cDNAs into  the hRK18 
vector, phagemid DNA aliqouts  representing  the  xcised pools were  xamined by 
restriction  analysis.  Representative  examples of successful  ligation reactions are shown in 
Figure 6 A, the excised  pRK18  vector in 6 B.  Note  that  the  smear between 1.3  and  2.3  kb 
representing the 500-1500 bp cDNAs (present in the 0.8 kb Hind IIVXba I fragment) is 
dominated by specific fragment lengths which differ between the individual cDNA pools. 
The weak 0.8 kb band in lane 1 and 3 - 7 indicates the presence of re-ligated pRK18 
without insert. This background appears  small  when the relative intensity between the 6.3, 
2.2  and  0.8 kb Hind IIIIHind 1 1 1  and Hind IIIIXba I vector  bands is compared to  the relative 
intensity of the corresponding  bands in the pRK18 x Hind IIIIXba I control (lane 2). 
The 60 phagemid DNA pools were realized in a total of 4 x lo6  YT455 
transformants and transferred to sucrose  plates  by  replica  plating. More than 500 sucrose 
positive transformants were  preliminarily  examined  by PCR on yeast  lysate and 
amplification products from  the  individual  pools  were subjected to insert size-alignment by 
gel electrophoresis, as a rough  means to detect  redundancy of positives. Accordingly, the 
3 - 500 terminal bases of l 1 0  inserts  from  sucrose  positive transformants were  sequence 
determined. By comparison to known DNA or amino acid sequences using the BLAST 
algorithm (http://w.ncbi.nlm.nih.gov/BLAST/) 18  inserts  were identified as unique known 
genes, included a signal  peptide  encoding  sequence  and  were found  to  be cloned in-frame 
with the signal peptide sequence deleted sucrose  gene  (Table 3). Two inserts (aocpl and 
aocp3 kssociated with  Qval sell proliferation)) showed no significant homology to known 
sequences at either  DNA or amino acid  level but were identified as expressed sequence 
tags (EST) (acc.  no.  A1233493  and  BE106481,  respectively),  one  (aocp4) showed 87% 
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Figure 6. A) Analysis of hRK18linset-l ligation efficiency by Hind IlllXba I digestion of pRKl8/insert DNA 
aliqouts  and  electrophoresis on a 1% agarose  gel.  Lane  1  represents the ligation of the 405 PAI-l positive 
control fragment, lane 3 - 7 represents the ligation of 500 - 1500 bp size fractionated cDNA from a 2- 
AAF/PHx treated rat 11 days post PHx. H/X = Hind IIIIXba I vector fragment, H/H = Hind Ill/ Hind 111 
fragment, M = DNA ladder. B) Schematic representation of the excised phagemid pRK18, showing the 
position of the Not I cloningsite, Hind 111 and  Xba I restriction sites and the relative  positions of E. coli and 
yeast markers for selection of transformants  and plasmid replication. 
identity at the DNA level to human NY-REN-25 antigen (acc no. AF155103) and one 
(aocp2) showed 89% identity to a homo sapiens EST encoding a putative calcium- 
transporting ATPase (acc no. A1371849). The putative polypeptides generated from the 
preliminary  sequence  data of the  inserts  which showed no or limited  homology to known 
sequences were analyzed by use of a computer program designed to search for signal 
peptides  (Nielsen  et  al.  1997) and as the prognoses were  positive all the  sequences  were 
further  examined. 
The  remainder of the 110 examined inserts mainly consisted in varying send 
truncations of the  hemopexin,  serum  albumin,  transferrin,  ceruloplasmin  or  corticosteroid 
binding  globulin  cDNAs,  but also in sequences which included a  signal  peptide  cloned  in 
the wrong orientation  or sequences encoding  internal  regions of polypeptides  localized to 
the  secretory  pathway  (data not shown). 
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Table 3. cDNA clones isolated from a  rat  liver at the 1 lth day after  the  combined  treatment of 2-AAF 
exposure and  a 70 % hepatectomy  in the 2-AAF/PHx  protocol  and  cloned by use of the SPS method. 
14 
Ml 1883. Furuto- Plasma glycoprotein. LMW T-kininogen; major 15 
Y1 1283. Soury eta/ The single  chain  member of the plasma protein family Plasma protein; 
etal(1981) 
Inter-alpha-inhibitor H4 (l 998) inter-alpha-inhibitor. 
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None  of the potential  candidates for identification by SPS analysis,  encoding 
secreted or membrane-bound proteins which are known to respond in the 2-AAF/PHx 
protocol by increased transcriptional activity, e.g. transforming growth factor-a (TGF-a), 
acidic  fibroblast  growth  factor  (aFGF),  hepatocyte  growth  factor  (HGF)  (Evarts et a/. 1993), 
stem  cell  factor  (SCF) and its  receptor c-kit (Fuji0 et a/. 1994),  the  fibroblast  growth  factor 
receptor-l and -2 (Hu et al. 1995), leukemia inhibitory factor (LIF) and its receptor LlFR 
(Omori et a/. 1996)  or  urokinase-type  plasminogen  activator  (uPA),  its  receptor  uPAR and 
plasminogen  activator inhibitor-l (PAI-l) (Bisgaard et al. 1998),  were cloned in the  present 
study. The absence of genes  which  are  known to be induced in the 2-AAF/PHx  model  may 
reflect a relatively low abundance of the corresponding transcripts within the total RNA 
pool as compared to the  identified  transcripts  e.g.  albumin and transferin  (proteins 
normally  produced and secreted  by  hepatocytes). 
3.2.4. Northern  blot  analysis of cDNAs  identified from the SPS library 
To examine for a possible role of the identified genes (Table 3) during liver 
damage and regeneration, particularly in regeneration from oval progenitor cells, the 
cDNAs  were  analyzed  by  Northern  blotting of RNA  extracted from livers of rats  exposed to 
experimental regimens inducing different regenerative responses (Figure 7). Three regi- 
mens represent responses which are known to induce either activation or activation, 
extensive  proliferation,  migration and differentiation of oval progenitor  cells; 
2-AAF  treatment  (Figure 7, lane B, H and K) inhibits mitotic  activity in hepatocytes and 
activates  oval  progenitor  cell  proliferation  in  bile ducts and ductules, as shown by [3H]- 
thymidine labeling and detection of the liver-specific transcription factors hepatocyte 
nuclear factor l p  (HNFlp), HNF3yand their target genes AFP and albumin, in the 
activated  structures  (Bisgaard  et  al.  1996). It was further shown that 2-AAF treatment 
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resulted in an increased number of apoptotic cells in portal areas, a process that 
contributed to  the overall retention of liver  morphology. 
When 2-AAF is combined with a 70% PHx  (Figure 7 lane G and J), inhibition of mitotic 
activity in hepatocytes and activation of oval progenitor cells are  followed  by  extensive 
proliferation, expansion into the liver parenchyma and differentiation of oval  progenitor 
cells (Nagy  et  al. 1994, Evarts et al.  1996). 
D-galactosamine exposure  (Figure 7 lane C) cause  parenchymal  necrosis  and  compro- 
mise  mitotic activity in hepatocytes for two days whereas  oval  progenitor  cells replicate 
at day 1 and subsequently differentiate into small hepatocytes (Lemire et al. 1991). 
Normal liver structure is restored within only 7 - 10 days after GalN  injection  (Lemire et 
a/, 1991) as mature hepatocytes make up an important  source of tissue  renewal. 
The  remaining  examined  regimens  are  known to induce  extensive  regenerative  responses 
but oval progenitor cell activity has not been reported in these  models; 
Ligation of the common bile duct  (BDL)  (Figure 7 lane E) induces bile duct  hyperplasia 
without penetration of the parenchyma (Lenzi et al.  1992)  or  expression of hepatocyte 
enriched transcription factors (Bisgaard et al.  1996). 
Removal of 90% of the liver mass (90%0 PHx)  without  toxic  injury to the  liver  (Figure 7 
lane M and N) stimulates all liver cell populations to proliferate (Tygstrup  et  al.  1996). 
Both acetaminophen intoxication (APAP)  (Figure 7 lane D) and  endotoxin stimulation 
(LPS)  (Figure 7 lane 0 and P) induce hepatic dysfunction  and  hepatocyte  death. 
Injection of NaCI, sham operation with laparotomy only and late stages of regeneration 
from 70% PHx  was  used as controls for the above regimens  (Figure 7 lane A, F, I and  L, 
respectively). 
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To verify oval cell activity in animals exposed to GalN and the 2-AAF/PHx 
protocol (Figure 7 lane  C,  G  and J), expression of the commonly  used  oval cell marker a- 
fetoprotein (AFP) was included  in the Northern  blot  analysis.  The observed signal intensity 
in the GalN and 2-AAFIPHx  protocols  is in accordance  with the relative presence of oval 
cells at the examined time points.  AFP  expression could not  be detected in the remaining 
examined regimens, reflecting the absence of significant oval cell response in these 
protocols. 
In general the Northern blots show  that  among the known  cDNAs,  only  CD45 
expression is specifically  associated  with the regimens  which extensively induce oval cell 
activity, whereas  expression of all the novel cDNAs  seems to  be associated with  oval cell 
activity. This pattern of differential expression is more clearly illustrated in Figure 8, in 
which the relative intensity of the Northern blot hybridization signals are quantified by 
densiometric scanning. The implications of the Northern blot analysis in the context of 
liver regeneration from  oval  progenitor cells are  further  analyzed  in  Paper II and  will not be 
commented any further in this chapter. Only, it should be noted that the Northern blot 
analysis in the case of complement component C6 revealed an additional hybridization 
signal which the BLAST database search could not account for. Significant alignment 
values were produced for  sequences from M. musculus  and H. sapiens only.  The  mRNA 
from these species are stated as 2.8 kb and 3.5 kb, respectively. The rat complement 
component C6 cDNA cloned in this study hybridized to RNA of approximately 3 kb but 
also  to RNA of approximately 0.8 kb.  Further, the relative intensity of the 3 kb and 0.8 kb 
signals was not identical  within  the individual regimens  (Figure 7). Northern blot analysis 
of the Fc  gamma  receptor cDNA did also produce hybridization signals in addition to the 
corresponding 1.5 kb mRNA, but in this case the BLAST search identified several 
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sequences from related Fc gamma receptor types (data not shown). As neither the 
complement component C6 nor the Fc gamma receptor was identified as specifically 
associated  with  regeneration in oval progenitor cell activating  protocols,  the  Northern  blot 
analysis  results  were  not paid any further attention in the  present  study. 
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Figure 7 .  Northern blot analysis of 
cDNAs identified by use of the 
Signal  Peptide  Selection method 
applied  on  a  cDNA library from 
the 1lth day of a rat liver 
regenerating in the  2-AAF/PHx 
regimen.  Hybridization of a- 
fetoprotein  (AFP)  ( igure 7 
continued) is shown to verify oval 
cell  activity.  Each  lane  was 
loaded  with 10 pg of total liver 
RNA isolated  from male  Wistar 
rats exposed to the  r gimens 
indicated  and sacrificed at the 
time  points  stated.  Control liver, 
(A); 2-acetylaminofluorene (2- 
AAF), (B, H, K); D-galactosamine 
(GalN), (C); acetaminophen 
(APAP),  (D): bile duct ligation 
(BDL), (E); sham  operation  with 
laparotomy  only  (Sham),  (F); 2- 
acetylamino-fluorene and 70% 
partial hepatectomy (2-AAF/PHx), 
(G, J): 70% partial hepatectomy 
(PHx), (l, L); 90% partial hepa- 
tectomy  (PHx go%), (M, N); 
lipopolysaccharide  (LPS), (0, P), 
PCR generated  copies  ofthe 
cloned  cDNAs  and  AFP  were  =P- 
labeled  and  used  for  hybridiza- 
tion. 
52 
Fc  gamma 
receptor 
Serum 
albumin 
Plasma 
protein 
LMW T- 
kininogen 
He aran 
sulPate 
proteoglycan 
Kidney injury 
molecule-l 
aocpl 
a o c ~ 2  
aocp3 
aocp4 
5 7 
days 
10  12 24 1224 
days  da S hr hr hr  
I ,-A 
2.0 kb 
3.0 kb 
2.1 kb 
3.4 kb 
2.2 kb 
1.1 kb 
0.8 kb 
1.4 kb 
1 kb 
5 kb 
1.8 kb 
3.5 kb 
Figure 7. Continued 
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Figure 8. Quantification of the  relative  expression  levels by densitometric  scanning of the Northern 
blot  analysis  (Figure 7). Expression values of the  individual  experimental  models  were  quantified  re- 
lative to  the control  liver in which the  density  value was set  to one. Note  that the scale of the Y-axis 
differs  between the diagrams.  Capitals  (X-axis) refer to  the  individual  regimens as in Figure 7. 
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4. Discussion 
Numerous  studies  have  described the functional and physical  properties of  oval 
cells  but  our  knowledge  concerning the molecular  mechanisms  which  regulate 
regeneration  from  this  cell  type  is  quite  limited. A mechanism for  priming of hepatocytes 
through  the  cascade  initiated  by TNF-a  and  IL-6 can, to a  great  extent,  explain  the  efficient 
response  after  PHx  treatment,  but the mechanism by  which  oval  cells  are  primed,  does  still 
appear  rather  unclarified.  The GalN protocol  demonstrates  that  the  oval cell response  can 
be  quite  fast,  but  oval  cells  are  not  significantly  involved  in the response to mass  reduction 
by PHx. The ability of oval cells to compensate for a reduced proliferative activity of 
hepatocytes  in IL-6 knockout  mice (Rosenberg et a/, 2000) further  indicates  that  different 
mechanisms  are  responsible  for the priming of hepatocytes and oval  cells. The majority of 
growth modulators known to be involved in regeneration after PHx treatment are also 
present  in regeneration  from  oval  cells. The prolonged  expression  and  individual 
characters of many of these growth modulators indicate their pleiotrophic functions as 
stimulators of migration and differentiation in addition to the proliferative effect (see 
chapter  1).  However,  the  expression of other factors  such  as SCF (Fuji0 et a/, 1994), IL- 
l p ,  IL-l8 and IFNy (Paper l), indicates, that regulatoly mechanisms exist, which are 
involved only when liver regeneration is effectuated by the activation, proliferation and 
differentiation of oval  cells. 
Considering  the  present  status  of  oval cell research,  a  mapping of differentially 
expressed  genes  seemed  as an appropriate means to enhance our  understanding of  the 
molecular  mechanisms  involved in regeneration  from  oval  cells.  Experimental  data 
provided  in  this  work,  concerning  genes  associated  with  oval cell activity,  are  summarized 
in  Table  4. A complete  mapping  is,  however, an extremely  resource  demanding  task. 
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Table 4. Summary of genes examined in  the present  study  which  were  found to be associated  with  oval 
cell activity. 
Gene products identified by SSH  or  SPS  combined  with  Northern  blot  analysis 
Cell surface receptor which exhibits ligand binding properties towards IFN-y (Arany et a/, 
-AAF/PHx  treatment  when the relative  abundance 
aocp2 
A1 371 849) encoding a putative calcium-transporting ATPase. Expression of transcript 
Novel cDNA cloned in the present study. 89% identity to homo sapiens EST (acc. no. 
increases in response to 2-AAF and 2-AAF/PHx treatment. Detected in several tissues of 
normal rat. 
aocp3 
treatment.  Detected in  several  tissues of normal  rat. 
Novel  cDNA  cloned  in  the  present study. 99% identity to rattus norvegicus EST (acc. no. 
BE106481) Expression of transcript increases  in  response to 2-AAF  and  2-AAF/PHx 
Gene name 1 Remarks 
I 
aocp4 
treatment.  Detected  in  several  tissues  of  normal  rat. 
Novel  cDNA  cloned  in  the  present  study.  87%  identity  to homo sapiens  NY-REN-25  antigen 
Additional  genes  studied by Northern blot analysis  and/or immunohistochemistry 
(acc.  no.  AF15503)  Expression  of  transcript  increases in  response  to  2-AAF and  Z-AAF/PHx 
IFN-y High affinity ligand of IFN-yRa (Boehm et a/, 1997). mRNA levels not detectable in normal 
liver  but  increases  to  low  levels  in  2-AAF  and  2-AF/PHx treated animals. 
/L- 18 Induces  IFN-y  production  in  T-lymphocytes (Okamura et a/, 1995). Transcript levels 
increases in response to 2-AAF and increases further when combined with PHx. IL-18 
protein  highly  expressed  in  sinusoidal lining cells as  well as in  the  ductular  structures of oval 
/C€ Induced  as  a  secondary  response  gene  by  IFN-y,  involved  in  the  activation of IL-lp and IL- 
18 (Gu et a/, 1997; Tamura et a/, 1995). Transcript levels increases in response  to 2-AAF 
and  increases  further  when  combined  with  PHx. Protein  detected over the ductular 
structures of oval  cells. 
Among NPC populations only oval cell structures stained  for IFN-yRP. Mature hepatocytes 
P-chain of the IFN-y receptor complex, involved primarily in  signaling (Boehm et a/, 1997). 
also  stained  (weakly)  positive. 
/FN-).Rp 
uPAR 
increases in response  to  2-AAF  and  2-AAF/PHx treatment. Protein  present in NPC 
Induced by IFN-y as a secondary response gene (Sitrin et a/, 1994). Transcript levels 
populations of bile  duct  and/or  oval  cells. 
uPA 
Z-AAF/PHx  treatment.  Protein  present in NPC populations of bile duct  and/or  oval  cells. 
Induced by IFN-y (Sitrin et a/, 1994). Transcript levels increases  in response  to 2-AAF anc 
/CAM- 1 Induced as a secondary response gene by IFN-y, binds to LFA-1 (Boehm et a/, 1997), 
Protein  present  in  NPC  populations of bile duct  and/or oval cells. 
and  Pagler,  1995).  Transcript  not  detectable in  normal liver. Transcript  expressed ir 
Membrane-anchored molecule which can interact with CD45 (Volarevic et a/, 1990; Altir 
response  to  2-AAF  treatment,  expression  level  increases further when combined with  PHx. 
Thy- 1 
SDF- l Sole  ligand  for  CXCR4  (Zou et a/, 1998).  High  steady state transcript level in normal liver, 
decreases in response 2-AAF  treatment and  decreases further  when combined  with  PHx. 
Table 4. Continued. 
In a recent study, Phillips et a/ (2000) applied an experimental approach based on 
subtracted cDNA libraries  from  highly  purified  murine fetal liver  hematopoietic  stem cells 
(FLHSC) in order to map the genetic program on which stem cell regulation  is  based, 5’ 
end sequencing of almost 6000 subtracted clones identified at least 161 transcription 
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factors, 174 cell-surface or membrane-associated molecules, 28 secreted proteins and 
147 signaling molecules. Many of the identified molecules were novel or found in stem 
cells  for  the  first  time. The efficacy of the  subtraction  was  verified  by  the  absence of p-actin 
and the retention or enrichment of gene products such as the marker of hematopoietic 
stem- and progenitor cells, CD34 (Krause et a/, 1996). The database representing the 
sequences of the  FLHSC  subtraction  libraries (http://stemcell.princeton.edu) includes 
several of the  molecules  (or  associated  molecules)  known to be expressed by oval  cells, 
e.g. uPAR, CAM-l, IL-6 receptor and IL-l8 receptor associated protein (Chapter 1 and 
Paper l). This  coincidence of molecules  associated  with  hematopoietic  stem cell and  oval 
cell activities  is  not  surprising,  considering the stem  cell-like  properties of  oval cells and  the 
ability of bone marrow stem cells to substitute hepatocytes in the presence of 2-AAF 
(Petersen et a/, 1999). A Blast search with aocpl-4 against the hematopoietic stem cell 
database  did  not  result  in  significant  hits. In addition to the incompleteness of  the 
database,  several  circumstances  can  account  for  this  lack of hits,  including the possibility 
aocpl-4 genes  are  not  expressed  by  oval  cells  themselves. Of the unknown  cDNAs  from 
the SSH library  (Table  2) only #SSH  clone l 1  2 (EST294771  from  normalized  rat  embryo), 
was  identical to an  EST sequence in the stem cell  database  (SC LL2 in  1451  8T7119945). 
In the present study, an approach based on SPS analysis was introduced in 
addition to the SSH analysis, in order to focus on the subgroup of oval cell associated 
molecules, which may be involved in the regulation of oval cell activities through an 
extracellular  destination  or  presence  on cell surfaces. The identified  genes  from  the  SSH 
and SPS libraries need to be analyzed further, but the genes that were examined more 
extensively  indicated  a  quite  interesting  aspect of oval cell regulation: A part  of the genes 
identified  from  the  SSH  library  (Paper l); IFN-yRa, gpglphox, IL-1(3, LFA-1,  elF-2- 
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associated 67-kd protein and AFP, are all implicated in the gene network connected to 
IFN-y. Their expression in the 2-AAF/PHx protocol was  analyzed by Northern  blotting  and 
immunohistochemistry  and  additional  components of the  gene  network; IFN-y itself, the p- 
subunit of the IFN-y receptor, the IFN-y induced uPA, three secondary response genes 
induced by  IFN-y (IL-l p-converting  enzyme (ICE), intercellular adhesion molecule-l 
(ICAM-l) and uPAR),  and  IL-18,  were  included  in  the  xpression analysis. All  the 
examined IFN-y-connected molecules turned out to be modulated in regeneration from 
oval cells. It was found that the IFN-y receptor a and p subunits and CAM-1 all were 
expressed on oval cells and Northern blot analysis revealed an increased expression of 
LFA-1. It was also shown that IL-18, a strong inducer of IFN-y production in T-cells 
(Okamura ef af, 1995), is expressed by oval  cells. Further, the ICE protein, a protease that 
converts IL-l8 precursors to an active form (Gu et a/, 1997), was detected over the 
ductular structures of oval cells,  indicating  that  oval cells not  only  can produce IL-l8 but 
also process  it to  an active  form. 
Of the known proteins identified from  the  SPS  library,  only  CD45 turned out as 
specifically associated with oval cell activity (Chapter 3; Paper H). This observation is, 
however, quite interesting, as CD45 may be a central factor in the microenvironmental 
changes orchestrating oval cell activity and which include the induction of the gene 
network connected to IFN-y.  The  CD45  isoform  cloned  from  the  SPS  library corresponds to 
the low molecular form (CD45RO-positive) predominantly expressed by memory T-cells 
(Akin and Sloan, 1997).  CD45  can  associate  with  the membrane-anchored oval cell 
marker Thy-l (Volarevic et a/, 1990;  Akin  and  Pagler,  1995;  Petersen et a/, 1998  a). Thy-l 
might be involved in cellular recognition, adhesion and T-cell activation (Williams, 1985; 
Huber et a/, 1992; Hozumi et a/, 1994). The increased expression of CD45 and Thy-l 
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which  associates  oval  cell  recruitment  (Paper II) thereby may reflect  that CD45 mediates  a 
contact  between  IFN-y  producing  T-lymphocytes and oval cells,  through Thy-l. This 
hypothesis  is  supported  by  the  observation  that  several  molecules  which  can  reinforce  the 
contact and mutual  stimulation  between  T-lymphocytes and oval  cells are induced  when 
oval cells are activated (Paper I; Paper 11); The membrane-bound molecule CAM-l  was 
found to be  extensively  expressed  by oval cells and the  expression of its  adhesion-partner, 
LFA-1,  has  been  found to be  highly  increased  on  the  surface of memory  T-cells  (Sanders 
et a/, 1988). ICAM-l and LFA-1 are both induced by IFN-y. Further, oval cells provide 
components for the regulation of IFN-y expression by the secretion of AFP and IL-18, 
which  inhibits  or  stimulates  IFN-y  production,  respectively  (Yamashita et a/, 1994; 
Okamura et a/, 1995). 
The chemokine  receptor  CXCR4 was among the genes  identified  from  the SSH 
library  (Chapter 3, Table 2). CXCR4  mRNA is expressed by lymphocytes  (Loetsher et a/, 
1994)  and  is  the  sole  receptor for the chemoattractant  stromal  cell  derived factor-l (SDF- 
1) (Zou et a/, 1998). SDF-l has  been  recognized as a  highly  efficient  inducer of 
lymphocyte  migration.  (Bleul et a/, 1996).  Both CXCR4 and SDF-1  expression  is 
modulated when oval cells are activated by 2-AAF (Paper 11,  Figure 5) and thereby 
appears to be  central  elements in the  pathway  by  which  T-lymphocytes  can  be  guided  to 
the localization of oval  cells. The SDF-l mRNA steady state level is high in normal liver, 
but  no  expression of CXCR4  can  be  detected  (Paper 11, Figure 5), indicating  that  SDF-1  is 
either  modified,  inhibitors  are  removed, or that  SDF-1  interacts  with  co-factors,  in  order to 
elicit  its  function as a  chemoattractant. The possible  scenario for an interaction  between  T- 
lymphocytes and oval  cells  is  illustrated in Figure 9. 
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Figure 9. Model representing the interactions between IFN-y producing T-lymphocytes and oval cells. 
CXCR4 and SDF-1 are central factors in the pathway involved in T-lymphocyte recruitment and the initial 
contact between the two cell types is established by CD45 and Thy-l. Paracrine and autocrine loops 
reinforce the contact and  the  exposure of oval cells to IFN-y. 
The functional implication(s) of a recruitment of IFN-y  producing T-lymphocytes 
when  oval cells are activated is not known.  However, for all examined  components of the 
gene  network connected to IFN-y,  IFN-y itself, SDF-1  and CXCR4, expression is 
modulated in response to 2-AAF alone, indicating a role for this system  in  an early phase 
of oval cell activation. The properties of IFN-y  include  orchestration of lymphocyte- 
endothelium interactions and effects on cell proliferation and  apoptosis,  but  more than 200 
genes are known to  be regulated by IFN-y, reflecting an extraordinary complexity of the 
IFN-y  response  (Boehm et a/, 1997). In mice  with a demonstrable  lack of  IFN-y mediated 
cellular responses,  due to targeted mutations in  the  IFN-y  genes, in the  gene  of  the only 
known receptor for IFN-y,  or the main  transcription  factor  which  mediates  IFN-y  responses, 
STAT-l, the only phenotypic abnormalities are  seen  in the  lymphoid  system  and 
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consequently heightened susceptibility to a variety of pathogens (Dalton et a/, 1993; 
Huang et a/, 1993; Meraz et a/, 1996). In  vitro studies by Marra et a/ (1996)  showed that 
DNA synthesis rates  were  only  slightly influenced by IFN-y itself but increased significantly 
when pre-treatment with  IFN-y  was  combined with exposure to growth factors like EGF. It 
therefore seems possible that IFN-y, through STAT-l, primes oval cells in vivo for the 
mitogenic effect  of  growth  factors. 
The  indications that IFN-y is  a  key molecule involved in an early phase  of oval 
cell activation, eventually as a priming factor, need to be examined more thoroughly. In 
case that the role of  IFN-y,  in protocols which induce an oval cell response, is parallel to 
the role of TNF-a in simple regeneration,  new treatment strategies can be implemented  in 
the clinic, e.g.  in the context  of pathological conditions which are characterized by 
uncontrolled growth  of oval cells.  A  more thoroughly examination of the role of IFN-y in the 
context of the data presented here, might include examination of CD45/CXCR4 co- 
expression from T-lymphocytes by immunohistochemical analysis or in situ hybridization. 
Ultimately, exposure  of  an IFNy deleted rat to the 2-AAF/PHx protocol would enlighten the 
importance of this cytokine. 
Recent  results  have demonstrated that cells of bone marrow origin can function 
as a source of several liver cell types (see chapter 1.4). As  an alternative to  the described 
hypothesis of T-lymphocyte recruitment in the 2-AAF and 2-AAF/PHx protocols, the 
modulation of CD45 CXCR4  and  LFA-1 expression observed in the present study (Paper I 
and  Paper II) might reflect a recruitment of hematopoietic progenitor cells.  Bone  marrow 
derived CD34' subpopulations, defined by CD45 isoform expression, have been studied 
by flow cytometry and  it  was  shown that the most primitive hematopoietic CD34' cells are 
CD45RO  positive  (Craig et a/, 1994).  SDF-1 is a highly efficacious lymphocyte 
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chemoattractant which mediates its effect through CXCR4 (Zou et a/, 1998; Bleul et a/, 
1996), but CXCR4 is expressed by primitive hematopoietic CD34+/Thy-l+ cells also  (Mohle 
et a/,1998). Human CD34' hematopoietic progenitor cells are attracted by bone marrow 
derived stromal cell SDF-1 (Aiuti et a/, 1997) why liver derived SDF-l may bring about a 
similar effect on this cell type. Further, LFA-1 and CAM-l ,  which were found to be 
associated  with regeneration from oval cells (Paper l), seems  important  in  the  process of 
hematopoietic stem cell homing too (Peled et a/, 2000). As both T-lymphocytes and 
hematopoietic progenitor cells can express molecules such  as  CXCR4,  CD45RO  and  LFA- 
l ,  Northern blot analysis alone does not account for the recruitment of a specific cell type 
when  the  liver  regenerates in the  2-AANPHx protocol.  Immunohistochemical  analyses will 
be more suitable to address this question. Recruitment of hematopoietic  progenitor  cells, 
rather than T-lymphocytes, in the 2-AAF  and  2-AAF/PHx  protocols  involve  the  existence of
an alternative to T-lymphocytes as a source of IFN-y production. IL-l p has  been  shown to 
induce IFN-y production in hepatocytes (Schroeder et a/, 1998)  and  the  induction of IL-l p 
in response to 2-AAF and 2-AAF/PHx (but also PHx alone) (Paper I) thereby makes 
hepatocytes to a possible source of IFN-y in the  2-AAF  and  2-AAF/PHx  protocols. 
However,  in the BMx  and WLTx experiments  by  Petersen et a/ (1999),  which  included  the 
2-AAF/CCI4 protocol, less than 0.2% of the hepatocytes were shown to originate from 
donor  bone  marrow at day 13  after hepatic injury. The  proportion of Thy-l+ cells of  donor 
origin was about 0.1% and the biological importance of cells  originating  from  bone 
marrow,  when  the  liver  regenerates in the 2-AAF/CCL protocol,  therefore  seems 
questionable. 
By use of the SPS approach (Chapter 3; Paper I I ) ,  four novel genes were 
identified as associated with oval cell proliferation. One of  these, aocpl, appeared 
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especially interesting, as its expression was exclusively restricted to the 2-AAF and 2- 
AAF/PHx  regimens.  Further,  in  tissues  of  normal  rats,  the aocpl transcript  was detected in 
testis  only.  The  latter  finding  might  reflect  that aocpl, like SCF-l, is  involved in 
spermatogenesis  as  well as the  stimulation of oval  cells  (Fuji0 et a/, 1994;  Loveland and 
Schlatt,  1997).  Identification of aocpl producing  cells, e.g. by immunohistochemical 
analysis  or in situ hybridization and identification of interacting  molecules, e.g.  by a yeast 
two hybrid screening of a  testis  library,  are  obvious  future  steps in the functional 
characterization of aocpl. 
Experimental  situations  have been described in which  renewal of  liver  cells, as 
well as fully differentiated cells of other tissues, involve tissue-specific adult stem cells 
(Petersen et a/, 1999; Theise et a/, 2000 a; Theise et a/, 2000 b; Kooy and Weiss, 2000). 
These recent  observations does not  only  indicate an extraordinary  plasticity of adult stem 
cells but also that  he  process of stem  cell  differentiation into mature  cell  types  is 
influenced by the  tissue-specific  microenvironment. The integrity of this microenvironment 
is  adequately  conserved in the  2-AAF/PHx and GalN  protocols to allow  complete 
regeneration  from oval cells, and apparently  destroyed in some  chronically  liver  diseases 
or poisoning in which the mechanisms controlling oval cell differentiation are absent. A 
complete  characterization of the  liver  microenvironment seems as a  quite  distant  prospect. 
However,  future mapping strategies based on  subtraction  cloning could be  directed 
towards  the  individual  pathological  situations and thereby  identify  relevant key molecules, 
e.g. by use of 2-AAF/PHx cDNAs as the tester population and cDNAs from an APAP 
poisoned liver  as  the  driver  population. 
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5. Concluding remarks 
Despite considerable research efforts during  the  past  years, surprisingly little is 
known about the molecular mechanisms which control the actions of oval cells in liver 
regeneration. The majority of studies  conducted so far, has  focused  on the role of factors 
known to  be involved in  regeneration  from  mature cell types. 
The experimental approaches,  based  on  Suppression  Subtractive Hybridization 
and Signal Peptide Selection, applied in the  present  study,  have demonstrated that 
regeneration from  oval cells differ from  simple  regeneration by the specific expression of 
several known and novel molecules. These findings include, that genes of the network 
connected to IFN-y  are specifically induced  when  oval cells are recruited for regeneration. 
Some members of this  network,  e.g.  the  receptor for IFN-y, CAM-1 and IL-18, are 
expressed by oval cells. Others,  like IFNy and  LFA-1,  appears to be characteristics of the 
changes in the microenvironment which associate  regeneration from oval cells. Additional 
microenvironmental alterations was demonstrated  by the modulation of CD45 CXCR4 and 
SDF-l expression. The increased expression  of CD45 LFA-1  and  CXCR4  may reflect that 
cells of  the hematopoietic system  are  recruited  when  liver  regeneration is accomplished by 
oval cells. Whether such hematopoietic cells are  represented  by oval cell stimulating IFN- 
yproducing T lymphocytes, or more primitive progenitor cells, which themselves can 
differentiate into liver cells, needs to be examined further. 
Finally, the detection of aocpl expression as highly restricted to  the 2-AAF and 
2-AAF/PHx protocols, as well as the  restricted  association  with testis among multiple adult 
tissues, indicates a central role of aocpl in the pathways associated with recruitment of 
oval cells for liver  regeneration. 
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Peter  Nagy,+  Lene Juel Rasmussen,'  and 
Fmm the D q a m e n t  of Lge Sciences and Chemistry,. Roskilde 
LkzvesiQ, Roskilde, Dmmmk; the First ZmtirUte of Pathology 
and &Oer?mental  Cancer  Research,'  Semmelweis  Medical 
Untuersiy, Budapest,  Hungary; and the  Laboratory of 
Experimatal Caninogmesiq? Division of Baric Sciences, 
National Cancer Instihrte, Nahonal Institutes of Health, 
Betbesda, Maryland 
Suppression subtractive hybridization was used to 
clone genes associated with proliferation of oval  cells 
in rat liver regenerating after a  70% partial hepatec- 
tomy  combined with the feeding of  2-aceiylaminonu- 
orene. A subset of the identified  genes  comprised inter- 
feron-y receptor or subunit @W-yRor), gp9lphox, 
interleukin-lp (ILlp), lymphocyte  function-associated 
molecule-lor  (LFA-l),  eukaryotic nitiation factor-2.- 
ciated 67-kd protein (eli-2-associated  67-kd  protein), 
and or-fetoprotein,  which  constitute part of the cellular 
program modulated by IFN-y. Therefore, expression 
analysis  performed  by Northern blotting and immuno- 
histochemistry were extended to indude IFN-y, the 
IFN-y receptor p subunit (W-yRp), three secondary 
response  genes  induced  by interaction of IFN-y with 
IFN-y receptor complexes, ie, IGlQconverting enzyme 
(ICE), intercellular  adhesion  molecule-l (ICAM-l), and 
urokinase-type  plasminogen  activator receptor (@m),- 
and a  cytokine  inducing IFN-y expression, ie, interleu- 
kin-18 ml@. The Northern blot analysis showed that 
all examined  genes  were  modulated when progenitor- 
like oval cells were activated and recruited for liver 
regeneration.  Immunohistochemistry  localized the sub- 
units of the IFN-y receptor complex, IFN-yRor and IFN- 
the IFN-y-inducing factor IG18, and ICE to the du- 
yRp, the secondaq' response  genes WAR and ICAM-l, 
structures of oval  cells. In contrast, during  liver  regen- 
tion of IGlg and ICE was observed. oui results, there. 
eration after a  70%  partial  hepatectomy, only modula- 
fore, indicate that IFN-y-mediated  events may be 
particularly important when cells in the bile  ductules 
must respond to liver  damage  by  production  of  ductular 
oval bells. [AmJ PathoC1999,155:1075-1085~ 
Selective Cloning  of Genes Encoding Secreted and 
Membrane-Bound Proteins with Putative Roles in Liver 
Regeneration from Oval Cells 
Sven Muller*, Niels Tygstrups, Lene aocpl, was exclusively expressed in the testis 
~~~l R ~ ~ ~ ~ ~ ~ ~ ~ * ,  and H ~~~ Cathrine indicating its putative role in both 
Bisgaard* spermatogenesis  and liver regeneration accomplished by recruitment of multi-potent 
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Regeneration  of the adult rat liver in response 
to severe  damage  can  be accomplished 
through the activation and differentiation of 
to be modulated by  altered expression of 
multi-potent oval cells. This process appears 
secreted and  membrane-bound growth 
modulators. To acquire further knowledge of 
the molecules involved, we  have  attempted to 
systematically identify genes encoding 
secreted and membrane-bound proteins, the 
expression of which is specifically associated 
with progenitor cell activity of the oval cell 
phenotype.  Since  secreted  and  membrane- 
bound proteins must pass through a secretory 
we have used a single-step, signal peptide 
pathway involving a signal peptide sequence, 
selection method in yeast to clone cDNA 
sequences from a rat liver containing 
numerous proliferating oval  cells.  Twenty two 
unique cDNAs encoding eighteen  k own 
membrane-bound  or  secreted  proteins,  and 
four novel proteins were identified. Northern 
blot analysis in various experimental models 
of liver damage and regeneration showed that 
encoding CD45 and of  the four novel 
increased expression of  one transcript 
transcripts was  associated with recruitment of 
oval cells. Additional expression analysis of 
genes linked to the function of  CD45,  (i.e. Thy- 
for CD45 in oval cell-based liver regeneration. 
l, CXCR4, and SDF-l) further indicated a role 
rat tissues revealed that one novel cDNA, 
Finally, Northern blot analysis  of multiple adult 
1 
